| RECORD |
SYMBOL |
NAME |
PRIORITY |
|
1
|
A2M
|
alpha-2-macroglobulin
|
3
|
|
2
|
AANAT
|
arylalkylamine N-acetyltransferase
|
2
|
|
3
|
ABCA1
|
ATP-binding cassette, sub-family A (ABC1), member 1
|
1
|
|
4
|
ABCA2
|
ATP-binding cassette, sub-family A (ABC1), member 2
|
2
|
|
5
|
ABCA4
|
ATP-binding cassette, sub-family A (ABC1), member 4
|
2
|
|
6
|
ABCA7
|
ATP-binding cassette, sub-family A (ABC1), member 7
|
1
|
|
7
|
ABCB1
|
ATP-binding cassette, sub-family B (MDR/TAP), member 1
|
2
|
|
8
|
ABCB11
|
ATP-binding cassette, sub-family B (MDR/TAP), member 11
|
2
|
|
9
|
ABCB4
|
ATP-binding cassette, sub-family B (MDR/TAP), member 4
|
2
|
|
10
|
ABCC1
|
ATP-binding cassette, sub-family C (CFTR/MRP), member 1
|
2
|
|
11
|
ABCC2
|
ATP-binding cassette, sub-family C (CFTR/MRP), member 2
|
2
|
|
12
|
ABCC3
|
ATP-binding cassette, sub-family C (CFTR/MRP), member 3
|
2
|
|
13
|
ABCC4
|
ATP-binding cassette, sub-family C (CFTR/MRP), member 4
|
2
|
|
14
|
ABCC5
|
ATP-binding cassette, sub-family C (CFTR/MRP), member 5
|
2
|
|
15
|
ABCC6
|
ATP-binding cassette, sub-family C (CFTR/MRP), member 6
|
3
|
|
16
|
ABCC8
|
ATP-binding cassette, sub-family C (CFTR/MRP), member 8
|
2
|
|
17
|
ABCC9
|
ATP-binding cassette, sub-family C (CFTR/MRP), member 9
|
2
|
|
18
|
ABCD1
|
ATP-binding cassette, sub-family D (ALD), member 1
|
2
|
|
19
|
ABCD2
|
ATP-binding cassette, sub-family D (ALD), member 2
|
2
|
|
20
|
ABCD3
|
ATP-binding cassette, sub-family D (ALD), member 3
|
2
|
|
21
|
ABCG1
|
ATP-binding cassette, sub-family G (WHITE), member 1
|
1
|
|
22
|
ABCG2
|
ATP-binding cassette, sub-family G (WHITE), member 2
|
2
|
|
23
|
ABCG4
|
ATP-binding cassette, sub-family G (WHITE), member 4
|
1
|
|
24
|
ABCG5
|
ATP-binding cassette, sub-family G (WHITE), member 5 (sterolin 1)
|
1
|
|
25
|
ABCG8
|
ATP-binding cassette, sub-family G (WHITE), member 8 (sterolin 2)
|
2
|
|
26
|
ABL2
|
v-abl Abelson murine leukemia viral oncogene homolog 2 (arg, Abelson-related gene)
|
2
|
|
27
|
ABO
|
ABO blood group (transferase A, alpha 1-3-N-acetylgalactosaminyltransferase; transferase B, alpha 1-3-galactosyltransferase)
|
2
|
|
28
|
ACACA
|
acetyl-Coenzyme A carboxylase alpha
|
3
|
|
29
|
ACADL
|
acyl-Coenzyme A dehydrogenase, long chain
|
2
|
|
30
|
ACADM
|
acyl-Coenzyme A dehydrogenase, C-4 to C-12 straight chain
|
2
|
|
31
|
ACADS
|
acyl-Coenzyme A dehydrogenase, C-2 to C-3 short chain
|
2
|
|
32
|
ACADVL
|
acyl-Coenzyme A dehydrogenase, very long chain
|
2
|
|
33
|
ACAN
|
aggrecan
|
2
|
|
34
|
ACAT1
|
acetyl-Coenzyme A acetyltransferase 1 (acetoacetyl Coenzyme A thiolase)
|
1
|
|
35
|
ACAT2
|
acetyl-Coenzyme A acetyltransferase 2 (acetoacetyl Coenzyme A thiolase)
|
1
|
|
36
|
ACE
|
angiotensin I converting enzyme (peptidyl-dipeptidase A) 1
|
1
|
|
37
|
ACE2
|
angiotensin I converting enzyme (peptidyl-dipeptidase A) 2
|
1
|
|
38
|
ACHE
|
acetylcholinesterase (Yt blood group)
|
2
|
|
39
|
ACOT11
|
acyl-CoA thioesterase 11
|
2
|
|
40
|
ACOT12
|
acyl-CoA thioesterase 12
|
2
|
|
41
|
ACP1
|
acid phosphatase 1, soluble
|
2
|
|
42
|
ACSM1
|
acyl-CoA synthetase medium-chain family member 1
|
2
|
|
43
|
ACSM2
|
acyl-CoA synthetase medium-chain family member 2
|
2
|
|
44
|
ACSM3
|
acyl-CoA synthetase medium-chain family member 3
|
2
|
|
45
|
ACSS2
|
acyl-CoA synthetase short-chain family member 2
|
2
|
|
46
|
ACTA1
|
actin, alpha 1, skeletal muscle
|
2
|
|
47
|
ACTA2
|
actin, alpha 2, smooth muscle, aorta
|
2
|
|
48
|
ACTC1
|
actin, alpha, cardiac muscle 1
|
2
|
|
49
|
ACTN1
|
actinin, alpha 1
|
3
|
|
50
|
ACTN3
|
actinin, alpha 3
|
2
|
|
51
|
ACVR1
|
activin A receptor, type I
|
3
|
|
52
|
ACVRL1
|
activin A receptor type II-like 1
|
2
|
|
53
|
ADA
|
adenosine deaminase
|
2
|
|
54
|
ADAM10
|
ADAM metallopeptidase domain 10
|
2
|
|
55
|
ADAM12
|
ADAM metallopeptidase domain 12 (meltrin alpha)
|
3
|
|
56
|
ADAM15
|
ADAM metallopeptidase domain 15 (metargidin)
|
2
|
|
57
|
ADAM17
|
ADAM metallopeptidase domain 17 (tumor necrosis factor, alpha, converting enzyme)
|
2
|
|
58
|
ADAM33
|
ADAM metallopeptidase domain 33
|
2
|
|
59
|
ADAM9
|
ADAM metallopeptidase domain 9 (meltrin gamma)
|
2
|
|
60
|
ADAMTS10
|
ADAM metallopeptidase with thrombospondin type 1 motif, 10
|
2
|
|
61
|
ADAMTSL1
|
ADAMTS-like 1
|
3
|
|
62
|
ADCY1
|
adenylate cyclase 1 (brain)
|
3
|
|
63
|
ADCY6
|
adenylate cyclase 6
|
2
|
|
64
|
ADD1
|
adducin 1 (alpha)
|
1
|
|
65
|
ADD2
|
adducin 2 (beta)
|
2
|
|
66
|
ADD3
|
adducin 3 (gamma)
|
2
|
|
67
|
ADH1A
|
alcohol dehydrogenase 1A (class I), alpha polypeptide
|
2
|
|
68
|
ADH1C
|
alcohol dehydrogenase 1C (class I), gamma polypeptide
|
2
|
|
69
|
ADIPOQ
|
adiponectin, C1Q and collagen domain containing
|
1
|
|
70
|
ADIPOR1
|
adiponectin receptor 1
|
1
|
|
71
|
ADIPOR2
|
adiponectin receptor 2
|
1
|
|
72
|
ADK
|
adenosine kinase
|
3
|
|
73
|
ADM
|
adrenomedullin
|
2
|
|
74
|
ADORA1
|
adenosine A1 receptor
|
2
|
|
75
|
ADORA2A
|
adenosine A2a receptor
|
2
|
|
76
|
ADORA3
|
adenosine A3 receptor
|
2
|
|
77
|
ADRA1A
|
adrenergic, alpha-1A-, receptor
|
1
|
|
78
|
ADRA1B
|
adrenergic, alpha-1B-, receptor
|
2
|
|
79
|
ADRA1D
|
adrenergic, alpha-1D-, receptor
|
2
|
|
80
|
ADRA2A
|
adrenergic, alpha-2A-, receptor
|
1
|
|
81
|
ADRA2B
|
adrenergic, alpha-2B-, receptor
|
1
|
|
82
|
ADRA2C
|
adrenergic, alpha-2C-, receptor
|
1
|
|
83
|
ADRB1
|
adrenergic, beta-1-, receptor
|
1
|
|
84
|
ADRB2
|
adrenergic, beta-2-, receptor, surface
|
1
|
|
85
|
ADRB3
|
adrenergic, beta-3-, receptor
|
1
|
|
86
|
ADRBK1
|
adrenergic, beta, receptor kinase 1
|
1
|
|
87
|
ADRBK2
|
adrenergic, beta, receptor kinase 2
|
2
|
|
88
|
AGER
|
advanced glycosylation end product-specific receptor
|
1
|
|
89
|
AGRP
|
agouti related protein homolog (mouse)
|
2
|
|
90
|
AGT
|
angiotensinogen (serpin peptidase inhibitor, clade A, member 8)
|
1
|
|
91
|
AGTR1
|
angiotensin II receptor, type 1
|
1
|
|
92
|
AGTR2
|
angiotensin II receptor, type 2
|
1
|
|
93
|
AGTRAP
|
angiotensin II receptor-associated protein
|
2
|
|
94
|
AGTRL1
|
angiotensin II receptor-like 1
|
2
|
|
95
|
AHCY
|
S-adenosylhomocysteine hydrolase
|
2
|
|
96
|
AHSG
|
alpha-2-HS-glycoprotein
|
2
|
|
97
|
AIF1
|
allograft inflammatory factor 1
|
3
|
|
98
|
AIFM1
|
apoptosis-inducing factor, mitochondrion-associated, 1
|
2
|
|
99
|
AKR1B1
|
aldo-keto reductase family 1, member B1 (aldose reductase)
|
2
|
|
100
|
AKR1B10
|
aldo-keto reductase family 1, member B10 (aldose reductase)
|
2
|
|
101
|
AKT1
|
v-akt murine thymoma viral oncogene homolog 1
|
1
|
|
102
|
AKT2
|
v-akt murine thymoma viral oncogene homolog 2
|
1
|
|
103
|
AKT3
|
v-akt murine thymoma viral oncogene homolog 3 (protein kinase B, gamma)
|
2
|
|
104
|
ALB
|
albumin
|
2
|
|
105
|
ALCAM
|
activated leukocyte cell adhesion molecule
|
2
|
|
106
|
ALDH1L1
|
aldehyde dehydrogenase 1 family, member L1
|
3
|
|
107
|
ALDH2
|
aldehyde dehydrogenase 2 family (mitochondrial)
|
1
|
|
108
|
ALMS1
|
Alstrom syndrome 1
|
3
|
|
109
|
ALOX12
|
arachidonate 12-lipoxygenase
|
1
|
|
110
|
ALOX12B
|
arachidonate 12-lipoxygenase, 12R type
|
2
|
|
111
|
ALOX15
|
arachidonate 15-lipoxygenase
|
1
|
|
112
|
ALOX15B
|
arachidonate 15-lipoxygenase, type B
|
1
|
|
113
|
ALOX5
|
arachidonate 5-lipoxygenase
|
1
|
|
114
|
ALOX5AP
|
arachidonate 5-lipoxygenase-activating protein
|
1
|
|
115
|
ALOXE3
|
arachidonate lipoxygenase 3
|
2
|
|
116
|
ALX4
|
aristaless-like homeobox 4
|
2
|
|
117
|
AMBP
|
alpha-1-microglobulin/bikunin precursor
|
2
|
|
118
|
AMPD1
|
adenosine monophosphate deaminase 1 (isoform M)
|
2
|
|
119
|
ANGPT1
|
angiopoietin 1
|
2
|
|
120
|
ANGPT2
|
angiopoietin 2
|
2
|
|
121
|
ANGPT4
|
angiopoietin 4
|
2
|
|
122
|
ANGPTL1
|
angiopoietin-like 1
|
2
|
|
123
|
ANGPTL2
|
angiopoietin-like 2
|
1
|
|
124
|
ANGPTL3
|
angiopoietin-like 3
|
1
|
|
125
|
ANGPTL4
|
angiopoietin-like 4
|
1
|
|
126
|
ANK1
|
ankyrin 1, erythrocytic
|
3
|
|
127
|
ANK2
|
ankyrin 2, neuronal
|
3
|
|
128
|
ANKRD40
|
ankyrin repeat domain 40
|
2
|
|
129
|
ANKRD45
|
ankyrin repeat domain 45
|
2
|
|
130
|
ANP32A
|
acidic (leucine-rich) nuclear phosphoprotein 32 family, member A
|
2
|
|
131
|
ANXA1
|
annexin A1
|
2
|
|
132
|
ANXA2
|
annexin A2
|
2
|
|
133
|
ANXA4
|
annexin A4
|
2
|
|
134
|
ANXA5
|
annexin A5
|
2
|
|
135
|
APAF1
|
apoptotic peptidase activating factor 1
|
2
|
|
136
|
APC
|
adenomatosis polyposis coli
|
2
|
|
137
|
APC2
|
adenomatosis polyposis coli 2
|
2
|
|
138
|
APCS
|
amyloid P component, serum
|
2
|
|
139
|
APLN
|
apelin, AGTRL1 ligand
|
2
|
|
140
|
APOA1
|
apolipoprotein A-I
|
1
|
|
141
|
APOA1BP
|
apolipoprotein A-I binding protein
|
2
|
|
142
|
APOA2
|
apolipoprotein A-II
|
1
|
|
143
|
APOA4
|
apolipoprotein A-IV
|
1
|
|
144
|
APOA5
|
apolipoprotein A-V
|
1
|
|
145
|
APOB
|
apolipoprotein B (including Ag(x) antigen)
|
1
|
|
146
|
APOBEC1
|
apolipoprotein B mRNA editing enzyme, catalytic polypeptide 1
|
1
|
|
147
|
APOC1
|
apolipoprotein C-I
|
1
|
|
148
|
APOC2
|
apolipoprotein C-II
|
1
|
|
149
|
APOC3
|
apolipoprotein C-III
|
1
|
|
150
|
APOC4
|
apolipoprotein C-IV
|
1
|
|
151
|
APOD
|
apolipoprotein D
|
1
|
|
152
|
APOE
|
apolipoprotein E
|
1
|
|
153
|
APOF
|
apolipoprotein F
|
2
|
|
154
|
APOH
|
apolipoprotein H (beta-2-glycoprotein I)
|
1
|
|
155
|
APOL1
|
apolipoprotein L, 1
|
1
|
|
156
|
APOM
|
apolipoprotein M
|
1
|
|
157
|
APP
|
amyloid beta (A4) precursor protein (peptidase nexin-II, Alzheimer disease)
|
1
|
|
158
|
AQP1
|
aquaporin 1 (Colton blood group)
|
2
|
|
159
|
AQP10
|
aquaporin 10
|
2
|
|
160
|
AQP3
|
aquaporin 3 (Gill blood group)
|
2
|
|
161
|
AR
|
androgen receptor (dihydrotestosterone receptor; testicular feminization; spinal and bulbar muscular atrophy; Kennedy disease)
|
1
|
|
162
|
ARAF
|
v-raf murine sarcoma 3611 viral oncogene homolog
|
2
|
|
163
|
ARG1
|
arginase, liver
|
2
|
|
164
|
ARG2
|
arginase, type II
|
2
|
|
165
|
ARHGAP4
|
Rho GTPase activating protein 4
|
2
|
|
166
|
ARHGAP5
|
Rho GTPase activating protein 5
|
2
|
|
167
|
ARHGAP6
|
Rho GTPase activating protein 6
|
2
|
|
168
|
ARHGDIB
|
Rho GDP dissociation inhibitor (GDI) beta
|
3
|
|
169
|
ARHGEF1
|
Rho guanine nucleotide exchange factor (GEF) 1
|
2
|
|
170
|
ARHGEF5
|
Rho guanine nucleotide exchange factor (GEF) 5
|
2
|
|
171
|
ARL6
|
ADP-ribosylation factor-like 6
|
2
|
|
172
|
ARMS2
|
age-related maculopathy susceptibility 2
|
2
|
|
173
|
ARNT
|
aryl hydrocarbon receptor nuclear translocator
|
1
|
|
174
|
ARNTL
|
aryl hydrocarbon receptor nuclear translocator-like
|
2
|
|
175
|
ARNTL2
|
aryl hydrocarbon receptor nuclear translocator-like 2
|
2
|
|
176
|
ARPC2
|
actin related protein 2/3 complex, subunit 2, 34kDa
|
2
|
|
177
|
ARSB
|
arylsulfatase B
|
3
|
|
178
|
ARTS-1
|
type 1 tumor necrosis factor receptor shedding aminopeptidase regulator
|
3
|
|
179
|
ARV1
|
ARV1 homolog (S. cerevisiae)
|
1
|
|
180
|
ASCC3
|
activating signal cointegrator 1 complex subunit 3
|
3
|
|
181
|
ASF1B
|
ASF1 anti-silencing function 1 homolog B (S. cerevisiae)
|
1
|
|
182
|
ASIP
|
agouti signaling protein, nonagouti homolog (mouse)
|
2
|
|
183
|
ASMT
|
acetylserotonin O-methyltransferase
|
1
|
|
184
|
ASPH
|
aspartate beta-hydroxylase
|
3
|
|
185
|
ATF1
|
activating transcription factor 1
|
2
|
|
186
|
ATF2
|
activating transcription factor 2
|
2
|
|
187
|
ATF6
|
activating transcription factor 6
|
3
|
|
188
|
ATIC
|
5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase/IMP cyclohydrolase
|
2
|
|
189
|
ATM
|
ataxia telangiectasia mutated (includes complementation groups A, C and D)
|
2
|
|
190
|
ATOH8
|
atonal homolog 8 (Drosophila)
|
2
|
|
191
|
ATP1A1
|
ATPase, Na+/K+ transporting, alpha 1 polypeptide
|
2
|
|
192
|
ATP1A2
|
ATPase, Na+/K+ transporting, alpha 2 (+) polypeptide
|
2
|
|
193
|
ATP1A3
|
ATPase, Na+/K+ transporting, alpha 3 polypeptide
|
2
|
|
194
|
ATP1B1
|
ATPase, Na+/K+ transporting, beta 1 polypeptide
|
2
|
|
195
|
ATP2A2
|
ATPase, Ca++ transporting, cardiac muscle, slow twitch 2
|
2
|
|
196
|
ATP2B1
|
ATPase, Ca++ transporting, plasma membrane 1
|
2
|
|
197
|
ATP2B4
|
ATPase, Ca++ transporting, plasma membrane 4
|
3
|
|
198
|
ATP5B
|
ATP synthase, H+ transporting, mitochondrial F1 complex, beta polypeptide
|
2
|
|
199
|
ATP5J
|
ATP synthase, H+ transporting, mitochondrial F0 complex, subunit F6
|
2
|
|
200
|
ATP6V1B1
|
ATPase, H+ transporting, lysosomal 56/58kDa, V1 subunit B1 (Renal tubular acidosis with deafness)
|
2
|
|
201
|
ATP6V1G2
|
ATPase, H+ transporting, lysosomal 13kDa, V1 subunit G2
|
3
|
|
202
|
ATP7A
|
ATPase, Cu++ transporting, alpha polypeptide (Menkes syndrome)
|
2
|
|
203
|
ATRX
|
alpha thalassemia/mental retardation syndrome X-linked (RAD54 homolog, S. cerevisiae)
|
1
|
|
204
|
AVP
|
arginine vasopressin (neurophysin II, antidiuretic hormone, diabetes insipidus, neurohypophyseal)
|
2
|
|
205
|
AVPR1A
|
arginine vasopressin receptor 1A
|
2
|
|
206
|
AVPR2
|
arginine vasopressin receptor 2 (nephrogenic diabetes insipidus)
|
2
|
|
207
|
AXIN1
|
axin 1
|
2
|
|
208
|
B2M
|
beta-2-microglobulin
|
2
|
|
209
|
BAD
|
BCL2-antagonist of cell death
|
1
|
|
210
|
BAG1
|
BCL2-associated athanogene
|
2
|
|
211
|
BAG3
|
BCL2-associated athanogene 3
|
2
|
|
212
|
BAG4
|
BCL2-associated athanogene 4
|
2
|
|
213
|
BAG5
|
BCL2-associated athanogene 5
|
2
|
|
214
|
BAI3
|
brain-specific angiogenesis inhibitor 3
|
3
|
|
215
|
BAK1
|
BCL2-antagonist/killer 1
|
1
|
|
216
|
BAT1
|
HLA-B associated transcript 1
|
2
|
|
217
|
BAX
|
BCL2-associated X protein
|
1
|
|
218
|
BBS1
|
Bardet-Biedl syndrome 1
|
2
|
|
219
|
BBS10
|
Bardet-Biedl syndrome 10
|
2
|
|
220
|
BBS12
|
Bardet-Biedl syndrome 12
|
3
|
|
221
|
BBS2
|
Bardet-Biedl syndrome 2
|
2
|
|
222
|
BBS4
|
Bardet-Biedl syndrome 4
|
2
|
|
223
|
BBS5
|
Bardet-Biedl syndrome 5
|
2
|
|
224
|
BBS7
|
Bardet-Biedl syndrome 7
|
3
|
|
225
|
BCAR1
|
breast cancer anti-estrogen resistance 1
|
3
|
|
226
|
BCDO2
|
beta-carotene dioxygenase 2
|
2
|
|
227
|
BCHE
|
butyrylcholinesterase
|
2
|
|
228
|
BCL2
|
B-cell CLL/lymphoma 2
|
1
|
|
229
|
BCL2A1
|
BCL2-related protein A1
|
2
|
|
230
|
BCL2L1
|
BCL2-like 1
|
1
|
|
231
|
BCL2L10
|
BCL2-like 10 (apoptosis facilitator)
|
2
|
|
232
|
BCL2L11
|
BCL2-like 11 (apoptosis facilitator)
|
3
|
|
233
|
BCL2L2
|
BCL2-like 2
|
2
|
|
234
|
BCL3
|
B-cell CLL/lymphoma 3
|
2
|
|
235
|
BCL9
|
B-cell CLL/lymphoma 9
|
2
|
|
236
|
BDK
|
bradykinin
|
2
|
|
237
|
BDKRB1
|
bradykinin receptor B1
|
3
|
|
238
|
BDKRB2
|
bradykinin receptor B2
|
2
|
|
239
|
BDNF
|
brain-derived neurotrophic factor
|
2
|
|
240
|
BHLHB2
|
basic helix-loop-helix domain containing, class B, 2
|
2
|
|
241
|
BHLHB3
|
basic helix-loop-helix domain containing, class B, 3
|
2
|
|
242
|
BHMT
|
betaine-homocysteine methyltransferase
|
2
|
|
243
|
BHMT2
|
betaine-homocysteine methyltransferase 2
|
2
|
|
244
|
BID
|
BH3 interacting domain death agonist
|
2
|
|
245
|
BIK
|
BCL2-interacting killer (apoptosis-inducing)
|
2
|
|
246
|
BIRC2
|
baculoviral IAP repeat-containing 2
|
2
|
|
247
|
BIRC3
|
baculoviral IAP repeat-containing 3
|
2
|
|
248
|
BIRC4
|
baculoviral IAP repeat-containing 4
|
2
|
|
249
|
BIRC8
|
baculoviral IAP repeat-containing 8
|
2
|
|
250
|
BLM
|
Bloom syndrome
|
2
|
|
251
|
BLR1
|
Burkitt lymphoma receptor 1, GTP binding protein (chemokine (C-X-C motif) receptor 5)
|
2
|
|
252
|
BMP10
|
bone morphogenetic protein 10
|
2
|
|
253
|
BMP2
|
bone morphogenetic protein 2
|
2
|
|
254
|
BMP4
|
bone morphogenetic protein 4
|
2
|
|
255
|
BMP5
|
bone morphogenetic protein 5
|
3
|
|
256
|
BMP6
|
bone morphogenetic protein 6
|
3
|
|
257
|
BMP7
|
bone morphogenetic protein 7 (osteogenic protein 1)
|
3
|
|
258
|
BMPR1A
|
bone morphogenetic protein receptor, type IA
|
3
|
|
259
|
BMPR1B
|
bone morphogenetic protein receptor, type IB
|
3
|
|
260
|
BMPR2
|
bone morphogenetic protein receptor, type II (serine/threonine kinase)
|
2
|
|
261
|
BOK
|
BCL2-related ovarian killer
|
2
|
|
262
|
BPI
|
bactericidal/permeability-increasing protein
|
3
|
|
263
|
BRAF
|
v-raf murine sarcoma viral oncogene homolog B1
|
3
|
|
264
|
BRCA2
|
breast cancer 2, early onset
|
2
|
|
265
|
BRIP1
|
BRCA1 interacting protein C-terminal helicase 1
|
2
|
|
266
|
BRS3
|
bombesin-like receptor 3
|
1
|
|
267
|
BSG
|
basigin (Ok blood group)
|
2
|
|
268
|
BSND
|
Bartter syndrome, infantile, with sensorineural deafness (Barttin)
|
2
|
|
269
|
BTK
|
Bruton agammaglobulinemia tyrosine kinase
|
2
|
|
270
|
BZW1
|
basic leucine zipper and W2 domains 1
|
2
|
|
271
|
C1QA
|
complement component 1, q subcomponent, A chain
|
2
|
|
272
|
C1QBP
|
complement component 1, q subcomponent binding protein
|
2
|
|
273
|
C1QTNF7
|
C1q and tumor necrosis factor related protein 7
|
3
|
|
274
|
C2
|
complement component 2
|
2
|
|
275
|
C20orf160
|
chromosome 20 open reading frame 160
|
2
|
|
276
|
C20orf27
|
chromosome 20 open reading frame 27
|
1
|
|
277
|
C21orf33
|
chromosome 21 open reading frame 33
|
3
|
|
278
|
C3
|
complement component 3
|
1
|
|
279
|
C4A
|
complement component 4A (Rodgers blood group)
|
2
|
|
280
|
C4B
|
complement component 4B (Childo blood group)
|
1
|
|
281
|
C5
|
complement component 5
|
3
|
|
282
|
C6
|
complement component 6
|
3
|
|
283
|
C7
|
complement component 7
|
3
|
|
284
|
C7orf10
|
chromosome 7 open reading frame 10
|
2
|
|
285
|
C8A
|
complement component 8, alpha polypeptide
|
2
|
|
286
|
C9
|
complement component 9
|
3
|
|
287
|
CABIN1
|
calcineurin binding protein 1
|
2
|
|
288
|
CACNA1C
|
calcium channel, voltage-dependent, L type, alpha 1C subunit
|
2
|
|
289
|
CADM1
|
cell adhesion molecule 1
|
2
|
|
290
|
CALCA
|
calcitonin/calcitonin-related polypeptide, alpha
|
2
|
|
291
|
CALCR
|
calcitonin receptor
|
3
|
|
292
|
CALCRL
|
calcitonin receptor-like
|
3
|
|
293
|
CALM1
|
calmodulin 1 (phosphorylase kinase, delta)
|
2
|
|
294
|
CALM2
|
calmodulin 2 (phosphorylase kinase, delta)
|
2
|
|
295
|
CALM3
|
calmodulin 3 (phosphorylase kinase, delta)
|
2
|
|
296
|
CALR
|
calreticulin
|
2
|
|
297
|
CALU
|
calumenin
|
2
|
|
298
|
CAMK1
|
calcium/calmodulin-dependent protein kinase I
|
2
|
|
299
|
CAMK1G
|
calcium/calmodulin-dependent protein kinase IG
|
2
|
|
300
|
CAMK2A
|
calcium/calmodulin-dependent protein kinase (CaM kinase) II alpha
|
3
|
|
301
|
CAMK2B
|
calcium/calmodulin-dependent protein kinase (CaM kinase) II beta
|
3
|
|
302
|
CAMK2D
|
calcium/calmodulin-dependent protein kinase (CaM kinase) II delta
|
3
|
|
303
|
CAMK2G
|
calcium/calmodulin-dependent protein kinase (CaM kinase) II gamma
|
2
|
|
304
|
CAMK4
|
calcium/calmodulin-dependent protein kinase IV
|
3
|
|
305
|
CAPN1
|
calpain 1, (mu/I) large subunit
|
3
|
|
306
|
CAPN10
|
calpain 10
|
1
|
|
307
|
CAPN2
|
calpain 2, (m/II) large subunit
|
3
|
|
308
|
CAPN5
|
calpain 5
|
2
|
|
309
|
CAPNS1
|
calpain, small subunit 1
|
1
|
|
310
|
CAPNS2
|
calpain, small subunit 2
|
2
|
|
311
|
CARTPT
|
CART prepropeptide
|
2
|
|
312
|
CASP1
|
caspase 1, apoptosis-related cysteine peptidase (interleukin 1, beta, convertase)
|
2
|
|
313
|
CASP10
|
caspase 10, apoptosis-related cysteine peptidase
|
3
|
|
314
|
CASP2
|
caspase 2, apoptosis-related cysteine peptidase (neural precursor cell expressed, developmentally down-regulated 2)
|
2
|
|
315
|
CASP3
|
caspase 3, apoptosis-related cysteine peptidase
|
1
|
|
316
|
CASP6
|
caspase 6, apoptosis-related cysteine peptidase
|
3
|
|
317
|
CASP7
|
caspase 7, apoptosis-related cysteine peptidase
|
3
|
|
318
|
CASP8
|
caspase 8, apoptosis-related cysteine peptidase
|
2
|
|
319
|
CASP9
|
caspase 9, apoptosis-related cysteine peptidase
|
1
|
|
320
|
CASQ2
|
calsequestrin 2 (cardiac muscle)
|
3
|
|
321
|
CASR
|
calcium-sensing receptor (hypocalciuric hypercalcemia 1, severe neonatal hyperparathyroidism)
|
2
|
|
322
|
CAST
|
calpastatin
|
3
|
|
323
|
CAT
|
catalase
|
2
|
|
324
|
CAV1
|
caveolin 1, caveolae protein, 22kDa
|
1
|
|
325
|
CAV2
|
caveolin 2
|
1
|
|
326
|
CAV3
|
caveolin 3
|
2
|
|
327
|
CBS
|
cystathionine-beta-synthase
|
2
|
|
328
|
CCKAR
|
cholecystokinin A receptor
|
2
|
|
329
|
CCKBR
|
cholecystokinin B receptor
|
3
|
|
330
|
CCL11
|
chemokine (C-C motif) ligand 11
|
2
|
|
331
|
CCL18
|
chemokine (C-C motif) ligand 18 (pulmonary and activation-regulated)
|
2
|
|
332
|
CCL2
|
chemokine (C-C motif) ligand 2
|
1
|
|
333
|
CCL20
|
chemokine (C-C motif) ligand 20
|
2
|
|
334
|
CCL21
|
chemokine (C-C motif) ligand 21
|
2
|
|
335
|
CCL24
|
chemokine (C-C motif) ligand 24
|
2
|
|
336
|
CCL26
|
chemokine (C-C motif) ligand 26
|
2
|
|
337
|
CCL27
|
chemokine (C-C motif) ligand 27
|
2
|
|
338
|
CCL28
|
chemokine (C-C motif) ligand 28
|
2
|
|
339
|
CCL5
|
chemokine (C-C motif) ligand 5
|
2
|
|
340
|
CCM2
|
cerebral cavernous malformation 2
|
2
|
|
341
|
CCR1
|
chemokine (C-C motif) receptor 1
|
2
|
|
342
|
CCR2
|
chemokine (C-C motif) receptor 2
|
1
|
|
343
|
CCR3
|
chemokine (C-C motif) receptor 3
|
3
|
|
344
|
CCR5
|
chemokine (C-C motif) receptor 5
|
1
|
|
345
|
CCR8
|
chemokine (C-C motif) receptor 8
|
2
|
|
346
|
CCR9
|
chemokine (C-C motif) receptor 9
|
2
|
|
347
|
CCRL2
|
chemokine (C-C motif) receptor-like 2
|
2
|
|
348
|
CCRN4L
|
CCR4 carbon catabolite repression 4-like (S. cerevisiae)
|
2
|
|
349
|
CD14
|
CD14 molecule
|
1
|
|
350
|
CD163
|
CD163 molecule
|
2
|
|
351
|
CD19
|
CD19 molecule
|
1
|
|
352
|
CD22
|
CD22 molecule
|
2
|
|
353
|
CD247
|
CD247 molecule
|
3
|
|
354
|
CD28
|
CD28 molecule
|
3
|
|
355
|
CD36
|
CD36 molecule (thrombospondin receptor)
|
1
|
|
356
|
CD37
|
CD37 molecule
|
2
|
|
357
|
CD3D
|
CD3d molecule, delta (CD3-TCR complex)
|
2
|
|
358
|
CD3E
|
CD3e molecule, epsilon (CD3-TCR complex)
|
2
|
|
359
|
CD3G
|
CD3g molecule, gamma (CD3-TCR complex)
|
2
|
|
360
|
CD4
|
CD4 molecule
|
3
|
|
361
|
CD40
|
CD40 molecule, TNF receptor superfamily member 5
|
2
|
|
362
|
CD40LG
|
CD40 ligand (TNF superfamily, member 5, hyper-IgM syndrome)
|
2
|
|
363
|
CD44
|
CD44 molecule (Indian blood group)
|
1
|
|
364
|
CD47
|
CD47 molecule
|
3
|
|
365
|
CD48
|
CD48 molecule
|
1
|
|
366
|
CD53
|
CD53 molecule
|
1
|
|
367
|
CD72
|
CD72 molecule
|
1
|
|
368
|
CD74
|
CD74 molecule, major histocompatibility complex, class II invariant chain
|
2
|
|
369
|
CD80
|
CD80 molecule
|
3
|
|
370
|
CD86
|
CD86 molecule
|
3
|
|
371
|
CD8A
|
CD8a molecule
|
2
|
|
372
|
CD97
|
CD97 molecule
|
2
|
|
373
|
CDH1
|
cadherin 1, type 1, E-cadherin (epithelial)
|
3
|
|
374
|
CDH12
|
cadherin 12, type 2 (N-cadherin 2)
|
3
|
|
375
|
CDH2
|
cadherin 2, type 1, N-cadherin (neuronal)
|
3
|
|
376
|
CDH5
|
cadherin 5, type 2, VE-cadherin (vascular epithelium)
|
2
|
|
377
|
CDIPT
|
CDP-diacylglycerol--inositol 3-phosphatidyltransferase (phosphatidylinositol synthase)
|
2
|
|
378
|
CDKN1A
|
cyclin-dependent kinase inhibitor 1A (p21, Cip1)
|
1
|
|
379
|
CDKN1B
|
cyclin-dependent kinase inhibitor 1B (p27, Kip1)
|
1
|
|
380
|
CDS1
|
CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 1
|
2
|
|
381
|
CDS2
|
CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 2
|
2
|
|
382
|
CEBPA
|
CCAAT/enhancer binding protein (C/EBP), alpha
|
1
|
|
383
|
CEBPB
|
CCAAT/enhancer binding protein (C/EBP), beta
|
1
|
|
384
|
CEL
|
carboxyl ester lipase (bile salt-stimulated lipase)
|
2
|
|
385
|
CES1
|
carboxylesterase 1 (monocyte/macrophage serine esterase 1)
|
1
|
|
386
|
CES2
|
carboxylesterase 2 (intestine, liver)
|
2
|
|
387
|
CES4
|
carboxylesterase 4-like
|
2
|
|
388
|
CETP
|
cholesteryl ester transfer protein, plasma
|
1
|
|
389
|
CFH
|
complement factor H
|
2
|
|
390
|
CFLAR
|
CASP8 and FADD-like apoptosis regulator
|
2
|
|
391
|
CFP
|
complement factor properdin
|
2
|
|
392
|
CFTR
|
cystic fibrosis transmembrane conductance regulator (ATP-binding cassette sub-family C, member 7)
|
3
|
|
393
|
CHAT
|
choline acetyltransferase
|
3
|
|
394
|
CHGB
|
chromogranin B (secretogranin 1)
|
2
|
|
395
|
CHIT1
|
chitinase 1 (chitotriosidase)
|
2
|
|
396
|
CHRD
|
chordin
|
2
|
|
397
|
CHRM1
|
cholinergic receptor, muscarinic 1
|
2
|
|
398
|
CHRM2
|
cholinergic receptor, muscarinic 2
|
3
|
|
399
|
CHRNA1
|
cholinergic receptor, nicotinic, alpha 1 (muscle)
|
2
|
|
400
|
CHUK
|
conserved helix-loop-helix ubiquitous kinase
|
1
|
|
401
|
CIB1
|
calcium and integrin binding 1 (calmyrin)
|
2
|
|
402
|
CIITA
|
class II, major histocompatibility complex, transactivator
|
2
|
|
403
|
CISH
|
cytokine inducible SH2-containing protein
|
2
|
|
404
|
CITED2
|
Cbp/p300-interacting transactivator, with Glu/Asp-rich carboxy-terminal domain, 2
|
2
|
|
405
|
CKM
|
creatine kinase, muscle
|
2
|
|
406
|
CLCA1
|
chloride channel, calcium activated, family member 1
|
3
|
|
407
|
CLCNKB
|
chloride channel Kb
|
2
|
|
408
|
CLNS1A
|
chloride channel, nucleotide-sensitive, 1A
|
2
|
|
409
|
CLNS1B
|
chloride channel, nucleotide-sensitive, 1B
|
2
|
|
410
|
CLOCK
|
clock homolog (mouse)
|
1
|
|
411
|
CLTA
|
clathrin, light chain (Lca)
|
2
|
|
412
|
CLTB
|
clathrin, light chain (Lcb)
|
2
|
|
413
|
CLTC
|
clathrin, heavy chain (Hc)
|
2
|
|
414
|
CLU
|
clusterin
|
3
|
|
415
|
CMA1
|
chymase 1, mast cell
|
2
|
|
416
|
CNDP1
|
carnosine dipeptidase 1 (metallopeptidase M20 family)
|
3
|
|
417
|
CNN1
|
calponin 1, basic, smooth muscle
|
2
|
|
418
|
CNP
|
2',3'-cyclic nucleotide 3' phosphodiesterase
|
2
|
|
419
|
CNR1
|
cannabinoid receptor 1 (brain)
|
2
|
|
420
|
CNR2
|
cannabinoid receptor 2 (macrophage)
|
1
|
|
421
|
CNTF
|
ciliary neurotrophic factor
|
2
|
|
422
|
COL11A1
|
collagen, type XI, alpha 1
|
2
|
|
423
|
COL11A2
|
collagen, type XI, alpha 2
|
2
|
|
424
|
COL1A1
|
collagen, type I, alpha 1
|
2
|
|
425
|
COL1A2
|
collagen, type I, alpha 2
|
2
|
|
426
|
COL24A1
|
collagen, type XXIV, alpha 1
|
2
|
|
427
|
COL2A1
|
collagen, type II, alpha 1 (primary osteoarthritis, spondyloepiphyseal dysplasia, congenital)
|
2
|
|
428
|
COL3A1
|
collagen, type III, alpha 1 (Ehlers-Danlos syndrome type IV, autosomal dominant)
|
2
|
|
429
|
COL4A1
|
collagen, type IV, alpha 1
|
2
|
|
430
|
COL4A2
|
collagen, type IV, alpha 2
|
3
|
|
431
|
COL4A3
|
collagen, type IV, alpha 3 (Goodpasture antigen)
|
3
|
|
432
|
COL4A3BP
|
collagen, type IV, alpha 3 (Goodpasture antigen) binding protein
|
2
|
|
433
|
COL4A4
|
collagen, type IV, alpha 4
|
3
|
|
434
|
COL4A5
|
collagen, type IV, alpha 5 (Alport syndrome)
|
2
|
|
435
|
COL4A6
|
collagen, type IV, alpha 6
|
2
|
|
436
|
COL5A1
|
collagen, type V, alpha 1
|
3
|
|
437
|
COL5A2
|
collagen, type V, alpha 2
|
2
|
|
438
|
COL8A1
|
collagen, type VIII, alpha 1
|
2
|
|
439
|
COL9A1
|
collagen, type IX, alpha 1
|
2
|
|
440
|
COL9A2
|
collagen, type IX, alpha 2
|
2
|
|
441
|
COMP
|
cartilage oligomeric matrix protein
|
2
|
|
442
|
COMT
|
catechol-O-methyltransferase
|
2
|
|
443
|
COPS5
|
COP9 constitutive photomorphogenic homolog subunit 5 (Arabidopsis)
|
2
|
|
444
|
CORIN
|
corin, serine peptidase
|
1
|
|
445
|
CPA6
|
carboxypeptidase A6
|
2
|
|
446
|
CPB2
|
carboxypeptidase B2 (plasma)
|
2
|
|
447
|
CPS1
|
carbamoyl-phosphate synthetase 1, mitochondrial
|
2
|
|
448
|
CPT1A
|
carnitine palmitoyltransferase 1A (liver)
|
2
|
|
449
|
CPT1B
|
carnitine palmitoyltransferase 1B (muscle)
|
2
|
|
450
|
CPT1C
|
carnitine palmitoyltransferase 1C
|
2
|
|
451
|
CPT2
|
carnitine palmitoyltransferase II
|
2
|
|
452
|
CRADD
|
CASP2 and RIPK1 domain containing adaptor with death domain
|
3
|
|
453
|
CRAT
|
carnitine acetyltransferase
|
2
|
|
454
|
CREB1
|
cAMP responsive element binding protein 1
|
2
|
|
455
|
CREBBP
|
CREB binding protein (Rubinstein-Taybi syndrome)
|
3
|
|
456
|
CREBL1
|
cAMP responsive element binding protein-like 1
|
2
|
|
457
|
CRHR1
|
corticotropin releasing hormone receptor 1
|
2
|
|
458
|
CRISPLD2
|
cysteine-rich secretory protein LCCL domain containing 2
|
3
|
|
459
|
CRKL
|
v-crk sarcoma virus CT10 oncogene homolog (avian)-like
|
2
|
|
460
|
CRLS1
|
cardiolipin synthase 1
|
2
|
|
461
|
CRMP1
|
collapsin response mediator protein 1
|
3
|
|
462
|
CROT
|
carnitine O-octanoyltransferase
|
3
|
|
463
|
CRP
|
C-reactive protein, pentraxin-related
|
1
|
|
464
|
CRY1
|
cryptochrome 1 (photolyase-like)
|
2
|
|
465
|
CRY2
|
cryptochrome 2 (photolyase-like)
|
1
|
|
466
|
CRYAB
|
crystallin, alpha B
|
2
|
|
467
|
CSF1
|
colony stimulating factor 1 (macrophage)
|
2
|
|
468
|
CSF1R
|
colony stimulating factor 1 receptor, formerly McDonough feline sarcoma viral (v-fms) oncogene homolog
|
3
|
|
469
|
CSF2
|
colony stimulating factor 2 (granulocyte-macrophage)
|
2
|
|
470
|
CSF2RA
|
colony stimulating factor 2 receptor, alpha, low-affinity (granulocyte-macrophage)
|
2
|
|
471
|
CSF2RB
|
colony stimulating factor 2 receptor, beta, low-affinity (granulocyte-macrophage)
|
2
|
|
472
|
CSF2RB2
|
colony stimulating factor 2 receptor, beta, 2
|
2
|
|
473
|
CSF3
|
colony stimulating factor 3 (granulocyte)
|
2
|
|
474
|
CSF3R
|
colony stimulating factor 3 receptor (granulocyte)
|
2
|
|
475
|
CSK
|
c-src tyrosine kinase
|
2
|
|
476
|
CSNK1A1
|
casein kinase 1, alpha 1
|
1
|
|
477
|
CSNK1D
|
casein kinase 1, delta
|
1
|
|
478
|
CSNK1E
|
casein kinase 1, epsilon
|
1
|
|
479
|
CSNK2A1
|
casein kinase 2, alpha 1 polypeptide
|
2
|
|
480
|
CSNK2A2
|
casein kinase 2, alpha prime polypeptide
|
1
|
|
481
|
CSNK2B
|
casein kinase 2, beta polypeptide
|
2
|
|
482
|
CSRP3
|
cysteine and glycine-rich protein 3 (cardiac LIM protein)
|
2
|
|
483
|
CST3
|
cystatin C (amyloid angiopathy and cerebral hemorrhage)
|
2
|
|
484
|
CSTB
|
cystatin B (stefin B)
|
2
|
|
485
|
CTDSP1
|
CTD (carboxy-terminal domain, RNA polymerase II, polypeptide A) small phosphatase 1
|
1
|
|
486
|
CTF1
|
cardiotrophin 1
|
1
|
|
487
|
CTGF
|
connective tissue growth factor
|
1
|
|
488
|
CTH
|
cystathionase (cystathionine gamma-lyase)
|
2
|
|
489
|
CTLA4
|
cytotoxic T-lymphocyte-associated protein 4
|
1
|
|
490
|
CTNNA1
|
catenin (cadherin-associated protein), alpha 1, 102kDa
|
2
|
|
491
|
CTNNB1
|
catenin (cadherin-associated protein), beta 1, 88kDa
|
2
|
|
492
|
CTSB
|
cathepsin B
|
2
|
|
493
|
CTSD
|
cathepsin D
|
2
|
|
494
|
CTSF
|
cathepsin F
|
2
|
|
495
|
CTSG
|
cathepsin G
|
2
|
|
496
|
CTSH
|
cathepsin H
|
2
|
|
497
|
CTSK
|
cathepsin K
|
2
|
|
498
|
CTSL1
|
cathepsin L1
|
2
|
|
499
|
CTSS
|
cathepsin S
|
2
|
|
500
|
CUBN
|
cubilin (intrinsic factor-cobalamin receptor)
|
2
|
|
501
|
CX3CL1
|
chemokine (C-X3-C motif) ligand 1
|
2
|
|
502
|
CX3CR1
|
chemokine (C-X3-C motif) receptor 1
|
2
|
|
503
|
CXCL1
|
chemokine (C-X-C motif) ligand 1 (melanoma growth stimulating activity, alpha)
|
2
|
|
504
|
CXCL10
|
chemokine (C-X-C motif) ligand 10
|
2
|
|
505
|
CXCL12
|
chemokine (C-X-C motif) ligand 12 (stromal cell-derived factor 1)
|
2
|
|
506
|
CXCL16
|
chemokine (C-X-C motif) ligand 16
|
2
|
|
507
|
CXCL2
|
chemokine (C-X-C motif) ligand 2
|
1
|
|
508
|
CXCR3
|
chemokine (C-X-C motif) receptor 3
|
1
|
|
509
|
CXCR4
|
chemokine (C-X-C motif) receptor 4
|
2
|
|
510
|
CYBA
|
cytochrome b-245, alpha polypeptide
|
1
|
|
511
|
CYBB
|
cytochrome b-245, beta polypeptide (chronic granulomatous disease)
|
2
|
|
512
|
CYCSP39
|
cytochrome c, somatic pseudogene 39
|
2
|
|
513
|
CYP11B1
|
cytochrome P450, family 11, subfamily B, polypeptide 1
|
2
|
|
514
|
CYP11B2
|
cytochrome P450, family 11, subfamily B, polypeptide 2
|
2
|
|
515
|
CYP17A1
|
cytochrome P450, family 17, subfamily A, polypeptide 1
|
2
|
|
516
|
CYP19A1
|
cytochrome P450, family 19, subfamily A, polypeptide 1
|
2
|
|
517
|
CYP1A1
|
cytochrome P450, family 1, subfamily A, polypeptide 1
|
1
|
|
518
|
CYP1A2
|
cytochrome P450, family 1, subfamily A, polypeptide 2
|
2
|
|
519
|
CYP1B1
|
cytochrome P450, family 1, subfamily B, polypeptide 1
|
2
|
|
520
|
CYP24A1
|
cytochrome P450, family 24, subfamily A, polypeptide 1
|
2
|
|
521
|
CYP26A1
|
cytochrome P450, family 26, subfamily A, polypeptide 1
|
2
|
|
522
|
CYP27A1
|
cytochrome P450, family 27, subfamily A, polypeptide 1
|
2
|
|
523
|
CYP27B1
|
cytochrome P450, family 27, subfamily B, polypeptide 1
|
1
|
|
524
|
CYP2A6
|
cytochrome P450, family 2, subfamily A, polypeptide 6
|
2
|
|
525
|
CYP2B6
|
cytochrome P450, family 2, subfamily B, polypeptide 6
|
3
|
|
526
|
CYP2C19
|
cytochrome P450, family 2, subfamily C, polypeptide 19
|
2
|
|
527
|
CYP2C8
|
cytochrome P450, family 2, subfamily C, polypeptide 8
|
2
|
|
528
|
CYP2C9
|
cytochrome P450, family 2, subfamily C, polypeptide 9
|
2
|
|
529
|
CYP2D6
|
cytochrome P450, family 2, subfamily D, polypeptide 6
|
2
|
|
530
|
CYP2E1
|
cytochrome P450, family 2, subfamily E, polypeptide 1
|
2
|
|
531
|
CYP2J2
|
cytochrome P450, family 2, subfamily J, polypeptide 2
|
2
|
|
532
|
CYP39A1
|
cytochrome P450, family 39, subfamily A, polypeptide 1
|
3
|
|
533
|
CYP3A
|
cytochrome P450, family 3, subfamily A
|
3
|
|
534
|
CYP3A4
|
cytochrome P450, family 3, subfamily A, polypeptide 4
|
1
|
|
535
|
CYP3A5
|
cytochrome P450, family 3, subfamily A, polypeptide 5
|
1
|
|
536
|
CYP4A11
|
cytochrome P450, family 4, subfamily A, polypeptide 11
|
2
|
|
537
|
CYP4B1
|
cytochrome P450, family 4, subfamily B, polypeptide 1
|
2
|
|
538
|
CYP4F2
|
cytochrome P450, family 4, subfamily F, polypeptide 2
|
1
|
|
539
|
CYP7A1
|
cytochrome P450, family 7, subfamily A, polypeptide 1
|
1
|
|
540
|
CYP7B1
|
cytochrome P450, family 7, subfamily B, polypeptide 1
|
2
|
|
541
|
CYP8B1
|
cytochrome P450, family 8, subfamily B, polypeptide 1
|
2
|
|
542
|
CYSLTR1
|
cysteinyl leukotriene receptor 1
|
2
|
|
543
|
CYSLTR2
|
cysteinyl leukotriene receptor 2
|
2
|
|
544
|
DAG1
|
dystroglycan 1 (dystrophin-associated glycoprotein 1)
|
2
|
|
545
|
DARC
|
Duffy blood group, chemokine receptor
|
2
|
|
546
|
DBH
|
dopamine beta-hydroxylase (dopamine beta-monooxygenase)
|
2
|
|
547
|
DBP
|
D site of albumin promoter (albumin D-box) binding protein
|
1
|
|
548
|
DCN
|
decorin
|
2
|
|
549
|
DDAH1
|
dimethylarginine dimethylaminohydrolase 1
|
2
|
|
550
|
DDAH2
|
dimethylarginine dimethylaminohydrolase 2
|
2
|
|
551
|
DDC
|
dopa decarboxylase (aromatic L-amino acid decarboxylase)
|
2
|
|
552
|
DDT
|
D-dopachrome tautomerase
|
1
|
|
553
|
DEFA1
|
defensin, alpha 1
|
2
|
|
554
|
DEFB1
|
defensin, beta 1
|
3
|
|
555
|
DES
|
desmin
|
2
|
|
556
|
DFFA
|
DNA fragmentation factor, 45kDa, alpha polypeptide
|
2
|
|
557
|
DFFB
|
DNA fragmentation factor, 40kDa, beta polypeptide (caspase-activated DNase)
|
3
|
|
558
|
DGAT1
|
diacylglycerol O-acyltransferase homolog 1 (mouse)
|
1
|
|
559
|
DGAT2
|
diacylglycerol O-acyltransferase homolog 2 (mouse)
|
2
|
|
560
|
DGCR
|
DiGeorge syndrome chromosome region
|
2
|
|
561
|
DHCR7
|
7-dehydrocholesterol reductase
|
2
|
|
562
|
DHFR
|
dihydrofolate reductase
|
2
|
|
563
|
DIABLO
|
diablo homolog (Drosophila)
|
2
|
|
564
|
DLC1
|
deleted in liver cancer 1
|
3
|
|
565
|
DLG3
|
discs, large homolog 3 (neuroendocrine-dlg, Drosophila)
|
1
|
|
566
|
DMGDH
|
dimethylglycine dehydrogenase
|
2
|
|
567
|
DMPK
|
dystrophia myotonica-protein kinase
|
2
|
|
568
|
DNAJB11
|
DnaJ (Hsp40) homolog, subfamily B, member 11
|
1
|
|
569
|
DNASE1
|
deoxyribonuclease I
|
2
|
|
570
|
DNMT1
|
DNA (cytosine-5-)-methyltransferase 1
|
1
|
|
571
|
DOK2
|
docking protein 2, 56kDa
|
1
|
|
572
|
DPP4
|
dipeptidyl-peptidase 4 (CD26, adenosine deaminase complexing protein 2)
|
1
|
|
573
|
DPYSL2
|
dihydropyrimidinase-like 2
|
3
|
|
574
|
DRD1
|
dopamine receptor D1
|
1
|
|
575
|
DRD2
|
dopamine receptor D2
|
2
|
|
576
|
DRD3
|
dopamine receptor D3
|
2
|
|
577
|
DRD4
|
dopamine receptor D4
|
2
|
|
578
|
DSG2
|
desmoglein 2
|
2
|
|
579
|
DSP
|
desmoplakin
|
3
|
|
580
|
DUSP1
|
dual specificity phosphatase 1
|
2
|
|
581
|
DUSP10
|
dual specificity phosphatase 10
|
3
|
|
582
|
DUSP2
|
dual specificity phosphatase 2
|
1
|
|
583
|
DUSP23
|
dual specificity phosphatase 23
|
1
|
|
584
|
DUSP4
|
dual specificity phosphatase 4
|
3
|
|
585
|
DUSP5
|
dual specificity phosphatase 5
|
2
|
|
586
|
DUSP6
|
dual specificity phosphatase 6
|
2
|
|
587
|
DUSP7
|
dual specificity phosphatase 7
|
2
|
|
588
|
DUSP9
|
dual specificity phosphatase 9
|
2
|
|
589
|
DVL1
|
dishevelled, dsh homolog 1 (Drosophila)
|
2
|
|
590
|
DVL1L1
|
dishevelled, dsh homolog 1 (Drosophila)-like 1
|
2
|
|
591
|
DYNLT1
|
dynein, light chain, Tctex-type 1
|
2
|
|
592
|
ECE1
|
endothelin converting enzyme 1
|
2
|
|
593
|
ECGF1
|
endothelial cell growth factor 1 (platelet-derived)
|
2
|
|
594
|
ECHS1
|
enoyl Coenzyme A hydratase, short chain, 1, mitochondrial
|
2
|
|
595
|
ECSIT
|
ECSIT homolog (Drosophila)
|
3
|
|
596
|
EDG1
|
endothelial differentiation, sphingolipid G-protein-coupled receptor, 1
|
1
|
|
597
|
EDG2
|
endothelial differentiation, lysophosphatidic acid G-protein-coupled receptor, 2
|
2
|
|
598
|
EDG3
|
endothelial differentiation, sphingolipid G-protein-coupled receptor, 3
|
2
|
|
599
|
EDG4
|
endothelial differentiation, lysophosphatidic acid G-protein-coupled receptor, 4
|
2
|
|
600
|
EDN1
|
endothelin 1
|
1
|
|
601
|
EDN2
|
endothelin 2
|
1
|
|
602
|
EDN3
|
endothelin 3
|
2
|
|
603
|
EDNRA
|
endothelin receptor type A
|
2
|
|
604
|
EDNRB
|
endothelin receptor type B
|
2
|
|
605
|
EGF
|
epidermal growth factor (beta-urogastrone)
|
2
|
|
606
|
EGFL7
|
EGF-like-domain, multiple 7
|
2
|
|
607
|
EGFR
|
epidermal growth factor receptor (erythroblastic leukemia viral (v-erb-b) oncogene homolog, avian)
|
2
|
|
608
|
EGR1
|
early growth response 1
|
2
|
|
609
|
EIF1
|
eukaryotic translation initiation factor 1
|
2
|
|
610
|
EIF1AX
|
eukaryotic translation initiation factor 1A, X-linked
|
2
|
|
611
|
EIF2A
|
eukaryotic translation initiation factor 2A, 65kDa
|
2
|
|
612
|
EIF2AK2
|
eukaryotic translation initiation factor 2-alpha kinase 2
|
3
|
|
613
|
EIF2AK3
|
eukaryotic translation initiation factor 2-alpha kinase 3
|
2
|
|
614
|
EIF2B1
|
eukaryotic translation initiation factor 2B, subunit 1 alpha, 26kDa
|
2
|
|
615
|
EIF2B2
|
eukaryotic translation initiation factor 2B, subunit 2 beta, 39kDa
|
2
|
|
616
|
EIF2B3
|
eukaryotic translation initiation factor 2B, subunit 3 gamma, 58kDa
|
3
|
|
617
|
EIF2B4
|
eukaryotic translation initiation factor 2B, subunit 4 delta, 67kDa
|
2
|
|
618
|
EIF2B5
|
eukaryotic translation initiation factor 2B, subunit 5 epsilon, 82kDa
|
1
|
|
619
|
EIF2S1
|
eukaryotic translation initiation factor 2, subunit 1 alpha, 35kDa
|
2
|
|
620
|
EIF2S2
|
eukaryotic translation initiation factor 2, subunit 2 beta, 38kDa
|
2
|
|
621
|
EIF2S3
|
eukaryotic translation initiation factor 2, subunit 3 gamma, 52kDa
|
2
|
|
622
|
ELA1
|
elastase 1, pancreatic
|
2
|
|
623
|
ELA2
|
elastase 2, neutrophil
|
2
|
|
624
|
ELA2A
|
elastase 2A
|
2
|
|
625
|
ELA2B
|
elastase 2B
|
2
|
|
626
|
ELA3B
|
elastase 3B, pancreatic
|
2
|
|
627
|
ELAVL1
|
ELAV (embryonic lethal, abnormal vision, Drosophila)-like 1 (Hu antigen R)
|
2
|
|
628
|
ELK1
|
ELK1, member of ETS oncogene family
|
2
|
|
629
|
ELN
|
elastin (supravalvular aortic stenosis, Williams-Beuren syndrome)
|
2
|
|
630
|
EMD
|
emerin (Emery-Dreifuss muscular dystrophy)
|
2
|
|
631
|
EMILIN1
|
elastin microfibril interfacer 1
|
2
|
|
632
|
EMP3
|
epithelial membrane protein 3
|
1
|
|
633
|
ENDOG
|
endonuclease G
|
2
|
|
634
|
ENG
|
endoglin (Osler-Rendu-Weber syndrome 1)
|
2
|
|
635
|
ENPP1
|
ectonucleotide pyrophosphatase/phosphodiesterase 1
|
2
|
|
636
|
ENTPD6
|
ectonucleoside triphosphate diphosphohydrolase 6 (putative function)
|
2
|
|
637
|
EP300
|
E1A binding protein p300
|
3
|
|
638
|
EPAS1
|
endothelial PAS domain protein 1
|
2
|
|
639
|
EPHA4
|
EPH receptor A4
|
3
|
|
640
|
EPHX1
|
epoxide hydrolase 1, microsomal (xenobiotic)
|
2
|
|
641
|
EPHX2
|
epoxide hydrolase 2, cytoplasmic
|
2
|
|
642
|
EPO
|
erythropoietin
|
1
|
|
643
|
EPOR
|
erythropoietin receptor
|
1
|
|
644
|
ERAF
|
erythroid associated factor
|
2
|
|
645
|
ERBB2
|
v-erb-b2 erythroblastic leukemia viral oncogene homolog 2, neuro/glioblastoma derived oncogene homolog (avian)
|
2
|
|
646
|
ERBB3
|
v-erb-b2 erythroblastic leukemia viral oncogene homolog 3 (avian)
|
1
|
|
647
|
ERBB4
|
v-erb-a erythroblastic leukemia viral oncogene homolog 4 (avian)
|
3
|
|
648
|
ERCC2
|
excision repair cross-complementing rodent repair deficiency, complementation group 2 (xeroderma pigmentosum D)
|
2
|
|
649
|
ERN1
|
endoplasmic reticulum to nucleus signalling 1
|
2
|
|
650
|
ERN2
|
endoplasmic reticulum to nucleus signalling 2
|
2
|
|
651
|
ESR1
|
estrogen receptor 1
|
1
|
|
652
|
ESR2
|
estrogen receptor 2 (ER beta)
|
1
|
|
653
|
ESRRA
|
estrogen-related receptor alpha
|
2
|
|
654
|
ETS1
|
v-ets erythroblastosis virus E26 oncogene homolog 1 (avian)
|
3
|
|
655
|
EVC
|
Ellis van Creveld syndrome
|
2
|
|
656
|
EXO1
|
exonuclease 1
|
2
|
|
657
|
EXT2
|
exostoses (multiple) 2
|
2
|
|
658
|
F10
|
coagulation factor X
|
2
|
|
659
|
F11
|
coagulation factor XI (plasma thromboplastin antecedent)
|
2
|
|
660
|
F11R
|
F11 receptor
|
2
|
|
661
|
F12
|
coagulation factor XII (Hageman factor)
|
1
|
|
662
|
F13A1
|
coagulation factor XIII, A1 polypeptide
|
2
|
|
663
|
F13B
|
coagulation factor XIII, B polypeptide
|
2
|
|
664
|
F2
|
coagulation factor II (thrombin)
|
1
|
|
665
|
F2R
|
coagulation factor II (thrombin) receptor
|
1
|
|
666
|
F2RL1
|
coagulation factor II (thrombin) receptor-like 1
|
1
|
|
667
|
F2RL2
|
coagulation factor II (thrombin) receptor-like 2
|
2
|
|
668
|
F2RL3
|
coagulation factor II (thrombin) receptor-like 3
|
1
|
|
669
|
F3
|
coagulation factor III (thromboplastin, tissue factor)
|
1
|
|
670
|
F5
|
coagulation factor V (proaccelerin, labile factor)
|
1
|
|
671
|
F7
|
coagulation factor VII (serum prothrombin conversion accelerator)
|
1
|
|
672
|
F8
|
coagulation factor VIII, procoagulant component (hemophilia A)
|
2
|
|
673
|
F9
|
coagulation factor IX (plasma thromboplastic component, Christmas disease, hemophilia B)
|
2
|
|
674
|
FAAH
|
fatty acid amide hydrolase
|
2
|
|
675
|
FABP1
|
fatty acid binding protein 1, liver
|
1
|
|
676
|
FABP2
|
fatty acid binding protein 2, intestinal
|
1
|
|
677
|
FABP3
|
fatty acid binding protein 3, muscle and heart (mammary-derived growth inhibitor)
|
2
|
|
678
|
FABP4
|
fatty acid binding protein 4, adipocyte
|
1
|
|
679
|
FABP6
|
fatty acid binding protein 6, ileal (gastrotropin)
|
2
|
|
680
|
FADD
|
Fas (TNFRSF6)-associated via death domain
|
1
|
|
681
|
FADS1
|
fatty acid desaturase 1
|
1
|
|
682
|
FADS2
|
fatty acid desaturase 2
|
2
|
|
683
|
FADS3
|
fatty acid desaturase 3
|
1
|
|
684
|
FAF1
|
Fas (TNFRSF6) associated factor 1
|
2
|
|
685
|
FANCA
|
Fanconi anemia, complementation group A
|
3
|
|
686
|
FANCB
|
Fanconi anemia, complementation group B
|
2
|
|
687
|
FANCC
|
Fanconi anemia, complementation group C
|
3
|
|
688
|
FANCD2
|
Fanconi anemia, complementation group D2
|
3
|
|
689
|
FANCE
|
Fanconi anemia, complementation group E
|
2
|
|
690
|
FANCF
|
Fanconi anemia, complementation group F
|
3
|
|
691
|
FANCG
|
Fanconi anemia, complementation group G
|
2
|
|
692
|
FANCL
|
Fanconi anemia, complementation group L
|
3
|
|
693
|
FANCM
|
Fanconi anemia, complementation group M
|
2
|
|
694
|
FAS
|
Fas (TNF receptor superfamily, member 6)
|
1
|
|
695
|
FASLG
|
Fas ligand (TNF superfamily, member 6)
|
2
|
|
696
|
FASN
|
fatty acid synthase
|
2
|
|
697
|
FBL
|
fibrillarin
|
2
|
|
698
|
FBLN1
|
fibulin 1
|
3
|
|
699
|
FBLN5
|
fibulin 5
|
3
|
|
700
|
FBN1
|
fibrillin 1
|
2
|
|
701
|
FBN2
|
fibrillin 2 (congenital contractural arachnodactyly)
|
3
|
|
702
|
FBN3
|
fibrillin 3
|
3
|
|
703
|
FCER1A
|
Fc fragment of IgE, high affinity I, receptor for; alpha polypeptide
|
2
|
|
704
|
FCGR2A
|
Fc fragment of IgG, low affinity IIa, receptor (CD32)
|
3
|
|
705
|
FCGR3A
|
Fc fragment of IgG, low affinity IIIa, receptor (CD16a)
|
2
|
|
706
|
FCGR3B
|
Fc fragment of IgG, low affinity IIIb, receptor (CD16b)
|
2
|
|
707
|
FDFT1
|
farnesyl-diphosphate farnesyltransferase 1
|
2
|
|
708
|
FDPS
|
farnesyl diphosphate synthase (farnesyl pyrophosphate synthetase, dimethylallyltranstransferase, geranyltranstransferase)
|
2
|
|
709
|
FEM1A
|
fem-1 homolog a (C. elegans)
|
1
|
|
710
|
FEM1B
|
fem-1 homolog b (C. elegans)
|
1
|
|
711
|
FFAR1
|
free fatty acid receptor 1
|
2
|
|
712
|
FGA
|
fibrinogen alpha chain
|
1
|
|
713
|
FGB
|
fibrinogen beta chain
|
1
|
|
714
|
FGF2
|
fibroblast growth factor 2 (basic)
|
2
|
|
715
|
FGF8
|
fibroblast growth factor 8 (androgen-induced)
|
2
|
|
716
|
FGG
|
fibrinogen gamma chain
|
1
|
|
717
|
FGL1
|
fibrinogen-like 1
|
2
|
|
718
|
FHL2
|
four and a half LIM domains 2
|
3
|
|
719
|
FHOD1
|
formin homology 2 domain containing 1
|
2
|
|
720
|
FKBP1A
|
FK506 binding protein 1A, 12kDa
|
2
|
|
721
|
FKBP1B
|
FK506 binding protein 1B, 12.6 kDa
|
2
|
|
722
|
FKRP
|
fukutin related protein
|
1
|
|
723
|
FLNA
|
filamin A, alpha (actin binding protein 280)
|
2
|
|
724
|
FLNC
|
filamin C, gamma (actin binding protein 280)
|
2
|
|
725
|
FLT1
|
fms-related tyrosine kinase 1 (vascular endothelial growth factor/vascular permeability factor receptor)
|
2
|
|
726
|
FLT3
|
fms-related tyrosine kinase 3
|
3
|
|
727
|
FLT4
|
fms-related tyrosine kinase 4
|
3
|
|
728
|
FN1
|
fibronectin 1
|
2
|
|
729
|
FOLH1
|
folate hydrolase (prostate-specific membrane antigen) 1
|
2
|
|
730
|
FOLR1
|
folate receptor 1 (adult)
|
2
|
|
731
|
FOLR2
|
folate receptor 2 (fetal)
|
2
|
|
732
|
FOLR3
|
folate receptor 3 (gamma)
|
2
|
|
733
|
FOS
|
v-fos FBJ murine osteosarcoma viral oncogene homolog
|
2
|
|
734
|
FOSL1
|
FOS-like antigen 1
|
2
|
|
735
|
FOXA2
|
forkhead box A2
|
2
|
|
736
|
FOXC1
|
forkhead box C1
|
1
|
|
737
|
FOXC2
|
forkhead box C2 (MFH-1, mesenchyme forkhead 1)
|
2
|
|
738
|
FOXJ1
|
forkhead box J1
|
1
|
|
739
|
FOXJ2
|
forkhead box J2
|
2
|
|
740
|
FOXJ3
|
forkhead box J3
|
2
|
|
741
|
FOXO1
|
forkhead box O1
|
2
|
|
742
|
FOXO3
|
forkhead box O3
|
2
|
|
743
|
FOXO4
|
forkhead box O4
|
1
|
|
744
|
FOXP1
|
forkhead box P1
|
3
|
|
745
|
FOXP2
|
forkhead box P2
|
2
|
|
746
|
FOXP4
|
forkhead box P4
|
2
|
|
747
|
FPGS
|
folylpolyglutamate synthase
|
2
|
|
748
|
FPRL1
|
formyl peptide receptor-like 1
|
2
|
|
749
|
FRMD4B
|
FERM domain containing 4B
|
2
|
|
750
|
FSHR
|
follicle stimulating hormone receptor
|
2
|
|
751
|
FTCD
|
formiminotransferase cyclodeaminase
|
2
|
|
752
|
FTO
|
fat mass and obesity associated
|
1
|
|
753
|
FURIN
|
furin (paired basic amino acid cleaving enzyme)
|
1
|
|
754
|
FUT3
|
fucosyltransferase 3 (galactoside 3(4)-L-fucosyltransferase, Lewis blood group)
|
2
|
|
755
|
FXN
|
frataxin
|
2
|
|
756
|
FXYD5
|
FXYD domain containing ion transport regulator 5
|
2
|
|
757
|
FYN
|
FYN oncogene related to SRC, FGR, YES
|
3
|
|
758
|
FZD1
|
frizzled homolog 1 (Drosophila)
|
1
|
|
759
|
FZD2
|
frizzled homolog 2 (Drosophila)
|
2
|
|
760
|
G6PD
|
glucose-6-phosphate dehydrogenase
|
2
|
|
761
|
GAA
|
glucosidase, alpha; acid (Pompe disease, glycogen storage disease type II)
|
2
|
|
762
|
GAB1
|
GRB2-associated binding protein 1
|
3
|
|
763
|
GAB2
|
GRB2-associated binding protein 2
|
2
|
|
764
|
GAB3
|
GRB2-associated binding protein 3
|
2
|
|
765
|
GABRA1
|
gamma-aminobutyric acid (GABA) A receptor, alpha 1
|
2
|
|
766
|
GABRA2
|
gamma-aminobutyric acid (GABA) A receptor, alpha 2
|
2
|
|
767
|
GABRA3
|
gamma-aminobutyric acid (GABA) A receptor, alpha 3
|
3
|
|
768
|
GABRA4
|
gamma-aminobutyric acid (GABA) A receptor, alpha 4
|
2
|
|
769
|
GABRA5
|
gamma-aminobutyric acid (GABA) A receptor, alpha 5
|
2
|
|
770
|
GABRA6
|
gamma-aminobutyric acid (GABA) A receptor, alpha 6
|
2
|
|
771
|
GAD2
|
glutamate decarboxylase 2 (pancreatic islets and brain, 65kDa)
|
2
|
|
772
|
GADD45A
|
growth arrest and DNA-damage-inducible, alpha
|
2
|
|
773
|
GADD45B
|
growth arrest and DNA-damage-inducible, beta
|
2
|
|
774
|
GADD45G
|
growth arrest and DNA-damage-inducible, gamma
|
2
|
|
775
|
GAL
|
galanin
|
2
|
|
776
|
GALNS
|
galactosamine (N-acetyl)-6-sulfate sulfatase (Morquio syndrome, mucopolysaccharidosis type IVA)
|
3
|
|
777
|
GALR1
|
galanin receptor 1
|
2
|
|
778
|
GAS6
|
growth arrest-specific 6
|
2
|
|
779
|
GAS7
|
growth arrest-specific 7
|
2
|
|
780
|
GATA1
|
GATA binding protein 1 (globin transcription factor 1)
|
1
|
|
781
|
GATA2
|
GATA binding protein 2
|
2
|
|
782
|
GATA3
|
GATA binding protein 3
|
3
|
|
783
|
GATA4
|
GATA binding protein 4
|
1
|
|
784
|
GATA5
|
GATA binding protein 5
|
2
|
|
785
|
GATA6
|
GATA binding protein 6
|
2
|
|
786
|
GBA
|
glucosidase, beta; acid (includes glucosylceramidase)
|
2
|
|
787
|
GBE1
|
glucan (1,4-alpha-), branching enzyme 1 (glycogen branching enzyme, Andersen disease, glycogen storage disease type IV)
|
3
|
|
788
|
GC
|
group-specific component (vitamin D binding protein)
|
2
|
|
789
|
GCG
|
glucagon
|
2
|
|
790
|
GCGR
|
glucagon receptor
|
2
|
|
791
|
GCH1
|
GTP cyclohydrolase 1 (dopa-responsive dystonia)
|
2
|
|
792
|
GCHFR
|
GTP cyclohydrolase I feedback regulator
|
2
|
|
793
|
GCK
|
glucokinase (hexokinase 4, maturity onset diabetes of the young 2)
|
1
|
|
794
|
GCKR
|
glucokinase (hexokinase 4) regulator
|
2
|
|
795
|
GCLM
|
glutamate-cysteine ligase, modifier subunit
|
2
|
|
796
|
GDF15
|
growth differentiation factor 15
|
2
|
|
797
|
GDNF
|
glial cell derived neurotrophic factor
|
3
|
|
798
|
GGCX
|
gamma-glutamyl carboxylase
|
2
|
|
799
|
GGH
|
gamma-glutamyl hydrolase (conjugase, folylpolygammaglutamyl hydrolase)
|
2
|
|
800
|
GH1
|
growth hormone 1
|
1
|
|
801
|
GH2
|
growth hormone 2
|
1
|
|
802
|
GHR
|
growth hormone receptor
|
2
|
|
803
|
GHRHR
|
growth hormone releasing hormone receptor
|
2
|
|
804
|
GHRL
|
ghrelin/obestatin preprohormone
|
2
|
|
805
|
GHSR
|
growth hormone secretagogue receptor
|
2
|
|
806
|
GIPR
|
gastric inhibitory polypeptide receptor
|
2
|
|
807
|
GJA1
|
gap junction protein, alpha 1, 43kDa
|
2
|
|
808
|
GJA4
|
gap junction protein, alpha 4, 37kDa
|
2
|
|
809
|
GJA5
|
gap junction protein, alpha 5, 40kDa
|
2
|
|
810
|
GJA7
|
gap junction protein, alpha 7, 45kDa
|
2
|
|
811
|
GJA9
|
gap junction protein, alpha 9, 36kDa
|
3
|
|
812
|
GLA
|
galactosidase, alpha
|
2
|
|
813
|
GLB1
|
galactosidase, beta 1
|
3
|
|
814
|
GLIPR1
|
GLI pathogenesis-related 1 (glioma)
|
1
|
|
815
|
GLP1R
|
glucagon-like peptide 1 receptor
|
3
|
|
816
|
GLP2R
|
glucagon-like peptide 2 receptor
|
2
|
|
817
|
GLRA1
|
glycine receptor, alpha 1 (startle disease/hyperekplexia, stiff man syndrome)
|
3
|
|
818
|
GMNN
|
geminin, DNA replication inhibitor
|
1
|
|
819
|
GNA12
|
guanine nucleotide binding protein (G protein) alpha 12
|
3
|
|
820
|
GNA13
|
guanine nucleotide binding protein (G protein), alpha 13
|
2
|
|
821
|
GNAI1
|
guanine nucleotide binding protein (G protein), alpha inhibiting activity polypeptide 1
|
2
|
|
822
|
GNAI2
|
guanine nucleotide binding protein (G protein), alpha inhibiting activity polypeptide 2
|
1
|
|
823
|
GNAQ
|
guanine nucleotide binding protein (G protein), q polypeptide
|
3
|
|
824
|
GNAS
|
GNAS complex locus
|
2
|
|
825
|
GNB1
|
guanine nucleotide binding protein (G protein), beta polypeptide 1
|
3
|
|
826
|
GNB3
|
guanine nucleotide binding protein (G protein), beta polypeptide 3
|
1
|
|
827
|
GNGT1
|
guanine nucleotide binding protein (G protein), gamma transducing activity polypeptide 1
|
3
|
|
828
|
GNMT
|
glycine N-methyltransferase
|
2
|
|
829
|
GP1BA
|
glycoprotein Ib (platelet), alpha polypeptide
|
2
|
|
830
|
GP1BB
|
glycoprotein Ib (platelet), beta polypeptide
|
2
|
|
831
|
GP5
|
glycoprotein V (platelet)
|
2
|
|
832
|
GP6
|
glycoprotein VI (platelet)
|
2
|
|
833
|
GPR109A
|
G protein-coupled receptor 109A
|
1
|
|
834
|
GPR109B
|
G protein-coupled receptor 109B
|
1
|
|
835
|
GPR133
|
G protein-coupled receptor 133
|
3
|
|
836
|
GPR44
|
G protein-coupled receptor 44
|
2
|
|
837
|
GPR55
|
G protein-coupled receptor 55
|
2
|
|
838
|
GPR81
|
G protein-coupled receptor 81
|
1
|
|
839
|
GPR98
|
G protein-coupled receptor 98
|
2
|
|
840
|
GPRC6A
|
G protein-coupled receptor, family C, group 6, member A
|
3
|
|
841
|
GPX1
|
glutathione peroxidase 1
|
1
|
|
842
|
GPX2
|
glutathione peroxidase 2 (gastrointestinal)
|
2
|
|
843
|
GPX3
|
glutathione peroxidase 3 (plasma)
|
2
|
|
844
|
GPX4
|
glutathione peroxidase 4 (phospholipid hydroperoxidase)
|
2
|
|
845
|
GPX5
|
glutathione peroxidase 5 (epididymal androgen-related protein)
|
2
|
|
846
|
GPX6
|
glutathione peroxidase 6 (olfactory)
|
2
|
|
847
|
GPX7
|
glutathione peroxidase 7
|
2
|
|
848
|
GRAP
|
GRB2-related adaptor protein
|
1
|
|
849
|
GRAP2
|
GRB2-related adaptor protein 2
|
3
|
|
850
|
GRB2
|
growth factor receptor-bound protein 2
|
1
|
|
851
|
GRK1
|
G protein-coupled receptor kinase 1
|
2
|
|
852
|
GRK4
|
G protein-coupled receptor kinase 4
|
2
|
|
853
|
GRK5
|
G protein-coupled receptor kinase 5
|
2
|
|
854
|
GRK6
|
G protein-coupled receptor kinase 6
|
2
|
|
855
|
GRK7
|
G protein-coupled receptor kinase 7
|
2
|
|
856
|
GRM3
|
glutamate receptor, metabotropic 3
|
2
|
|
857
|
GRN
|
granulin
|
2
|
|
858
|
GSK3B
|
glycogen synthase kinase 3 beta
|
1
|
|
859
|
GSR
|
glutathione reductase
|
2
|
|
860
|
GSS
|
glutathione synthetase
|
2
|
|
861
|
GSTA1
|
glutathione S-transferase A1
|
2
|
|
862
|
GSTM1
|
glutathione S-transferase M1
|
2
|
|
863
|
GSTM2
|
glutathione S-transferase M2 (muscle)
|
2
|
|
864
|
GSTM3
|
glutathione S-transferase M3 (brain)
|
2
|
|
865
|
GSTO1
|
glutathione S-transferase omega 1
|
2
|
|
866
|
GSTO2
|
glutathione S-transferase omega 2
|
2
|
|
867
|
GSTP1
|
glutathione S-transferase pi
|
2
|
|
868
|
GSTT1
|
glutathione S-transferase theta 1
|
2
|
|
869
|
GTSE1
|
G-2 and S-phase expressed 1
|
2
|
|
870
|
GUCY1B2
|
guanylate cyclase 1, soluble, beta 2
|
3
|
|
871
|
GYS1
|
glycogen synthase 1 (muscle)
|
2
|
|
872
|
GYS2
|
glycogen synthase 2 (liver)
|
3
|
|
873
|
GZF1
|
GDNF-inducible zinc finger protein 1
|
2
|
|
874
|
GZMB
|
granzyme B (granzyme 2, cytotoxic T-lymphocyte-associated serine esterase 1)
|
3
|
|
875
|
GZMH
|
granzyme H (cathepsin G-like 2, protein h-CCPX)
|
2
|
|
876
|
HABP2
|
hyaluronan binding protein 2
|
2
|
|
877
|
HADHA
|
hydroxyacyl-Coenzyme A dehydrogenase/3-ketoacyl-Coenzyme A thiolase/enoyl-Coenzyme A hydratase (trifunctional protein), alpha subunit
|
2
|
|
878
|
HAND1
|
heart and neural crest derivatives expressed 1
|
2
|
|
879
|
HAND2
|
heart and neural crest derivatives expressed 2
|
2
|
|
880
|
HAS1
|
hyaluronan synthase 1
|
2
|
|
881
|
HAS2
|
hyaluronan synthase 2
|
2
|
|
882
|
HAS3
|
hyaluronan synthase 3
|
2
|
|
883
|
HAT1
|
histone acetyltransferase 1
|
2
|
|
884
|
HAVCR2
|
hepatitis A virus cellular receptor 2
|
1
|
|
885
|
HBA1
|
hemoglobin, alpha 1
|
1
|
|
886
|
HBA2
|
hemoglobin, alpha 2
|
1
|
|
887
|
HBB
|
hemoglobin, beta
|
2
|
|
888
|
HBD
|
hemoglobin, delta
|
2
|
|
889
|
HBE1
|
hemoglobin, epsilon 1
|
2
|
|
890
|
HBEGF
|
heparin-binding EGF-like growth factor
|
2
|
|
891
|
HBG1
|
hemoglobin, gamma A
|
2
|
|
892
|
HBG2
|
hemoglobin, gamma G
|
2
|
|
893
|
HCFC1R1
|
host cell factor C1 regulator 1 (XPO1 dependent)
|
2
|
|
894
|
HCN2
|
hyperpolarization activated cyclic nucleotide-gated potassium channel 2
|
2
|
|
895
|
HCN4
|
hyperpolarization activated cyclic nucleotide-gated potassium channel 4
|
2
|
|
896
|
HCP5
|
HLA complex P5
|
3
|
|
897
|
HCRT
|
hypocretin (orexin) neuropeptide precursor
|
2
|
|
898
|
HCRTR2
|
hypocretin (orexin) receptor 2
|
2
|
|
899
|
HDAC2
|
histone deacetylase 2
|
1
|
|
900
|
HDAC3
|
histone deacetylase 3
|
2
|
|
901
|
HDAC4
|
histone deacetylase 4
|
2
|
|
902
|
HDAC5
|
histone deacetylase 5
|
2
|
|
903
|
HDAC6
|
histone deacetylase 6
|
2
|
|
904
|
HDAC7A
|
histone deacetylase 7A
|
2
|
|
905
|
HDAC8
|
histone deacetylase 8
|
2
|
|
906
|
HDAC9
|
histone deacetylase 9
|
3
|
|
907
|
HDLBP
|
high density lipoprotein binding protein (vigilin)
|
1
|
|
908
|
HEXB
|
hexosaminidase B (beta polypeptide)
|
2
|
|
909
|
HFE
|
hemochromatosis
|
2
|
|
910
|
HGF
|
hepatocyte growth factor (hepapoietin A; scatter factor)
|
2
|
|
911
|
HHEX
|
hematopoietically expressed homeobox
|
1
|
|
912
|
HIC1
|
hypermethylated in cancer 1
|
2
|
|
913
|
HIF1A
|
hypoxia-inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor)
|
1
|
|
914
|
HLA-B
|
major histocompatibility complex, class I, B
|
2
|
|
915
|
HLA-DMA
|
major histocompatibility complex, class II, DM alpha
|
2
|
|
916
|
HLA-DMB
|
major histocompatibility complex, class II, DM beta
|
2
|
|
917
|
HLA-DPA1
|
major histocompatibility complex, class II, DP alpha 1
|
2
|
|
918
|
HLA-DPB1
|
major histocompatibility complex, class II, DP beta 1
|
3
|
|
919
|
HLA-DQA1
|
major histocompatibility complex, class II, DQ alpha 1
|
2
|
|
920
|
HLA-DQB1
|
major histocompatibility complex, class II, DQ beta 1
|
2
|
|
921
|
HLA-DRA
|
major histocompatibility complex, class II, DR alpha
|
2
|
|
922
|
HLA-DRB1
|
major histocompatibility complex, class II, DR beta 1
|
2
|
|
923
|
HLA-G
|
HLA-G histocompatibility antigen, class I, G
|
2
|
|
924
|
HMBS
|
hydroxymethylbilane synthase
|
2
|
|
925
|
HMGA1
|
high mobility group AT-hook 1
|
1
|
|
926
|
HMGA2
|
high mobility group AT-hook 2
|
2
|
|
927
|
HMGCL
|
3-hydroxymethyl-3-methylglutaryl-Coenzyme A lyase (hydroxymethylglutaricaciduria)
|
3
|
|
928
|
HMGCR
|
3-hydroxy-3-methylglutaryl-Coenzyme A reductase
|
1
|
|
929
|
HMGCS1
|
3-hydroxy-3-methylglutaryl-Coenzyme A synthase 1 (soluble)
|
1
|
|
930
|
HMGCS2
|
3-hydroxy-3-methylglutaryl-Coenzyme A synthase 2 (mitochondrial)
|
2
|
|
931
|
HMOX1
|
heme oxygenase (decycling) 1
|
1
|
|
932
|
HNF4A
|
hepatocyte nuclear factor 4, alpha
|
1
|
|
933
|
HNRPUL1
|
heterogeneous nuclear ribonucleoprotein U-like 1
|
2
|
|
934
|
HOP
|
homeodomain-only protein
|
2
|
|
935
|
HOXC@
|
homeobox C cluster
|
2
|
|
936
|
HP
|
haptoglobin
|
2
|
|
937
|
HPGD
|
hydroxyprostaglandin dehydrogenase 15-(NAD)
|
2
|
|
938
|
HPR
|
haptoglobin-related protein
|
2
|
|
939
|
HPX
|
hemopexin
|
2
|
|
940
|
HRAS
|
v-Ha-ras Harvey rat sarcoma viral oncogene homolog
|
2
|
|
941
|
HRG
|
histidine-rich glycoprotein
|
2
|
|
942
|
HRH1
|
histamine receptor H1
|
2
|
|
943
|
HRH2
|
histamine receptor H2
|
2
|
|
944
|
HSD11B1
|
hydroxysteroid (11-beta) dehydrogenase 1
|
2
|
|
945
|
HSD11B2
|
hydroxysteroid (11-beta) dehydrogenase 2
|
2
|
|
946
|
HSD17B4
|
hydroxysteroid (17-beta) dehydrogenase 4
|
3
|
|
947
|
HSD3B1
|
hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 1
|
2
|
|
948
|
HSH2D
|
hematopoietic SH2 domain containing
|
2
|
|
949
|
HSP40
|
HSP40 pseudogene
|
2
|
|
950
|
HSP90AA1
|
heat shock protein 90kDa alpha (cytosolic), class A member 1
|
2
|
|
951
|
HSP90AB1
|
heat shock protein 90kDa alpha (cytosolic), class B member 1
|
2
|
|
952
|
HSP90B1
|
heat shock protein 90kDa beta (Grp94), member 1
|
2
|
|
953
|
HSPA1A
|
heat shock 70kDa protein 1A
|
1
|
|
954
|
HSPA1B
|
heat shock 70kDa protein 1B
|
2
|
|
955
|
HSPA1L
|
heat shock 70kDa protein 1-like
|
2
|
|
956
|
HSPA8
|
heat shock 70kDa protein 8
|
2
|
|
957
|
HSPB2
|
heat shock 27kDa protein 2
|
2
|
|
958
|
HSPB7
|
heat shock 27kDa protein family, member 7 (cardiovascular)
|
2
|
|
959
|
HSPBP1
|
hsp70-interacting protein
|
2
|
|
960
|
HTR1A
|
5-hydroxytryptamine (serotonin) receptor 1A
|
1
|
|
961
|
HTR1B
|
5-hydroxytryptamine (serotonin) receptor 1B
|
2
|
|
962
|
HTR2A
|
5-hydroxytryptamine (serotonin) receptor 2A
|
2
|
|
963
|
HTR2B
|
5-hydroxytryptamine (serotonin) receptor 2B
|
1
|
|
964
|
HTR2C
|
5-hydroxytryptamine (serotonin) receptor 2C
|
3
|
|
965
|
HTR3A
|
5-hydroxytryptamine (serotonin) receptor 3A
|
2
|
|
966
|
HTR3B
|
5-hydroxytryptamine (serotonin) receptor 3B
|
2
|
|
967
|
HTR3C
|
5-hydroxytryptamine (serotonin) receptor 3, family member C
|
2
|
|
968
|
HTR3D
|
5-hydroxytryptamine (serotonin) receptor 3 family member D
|
2
|
|
969
|
HTR3E
|
5-hydroxytryptamine (serotonin) receptor 3, family member E
|
2
|
|
970
|
HYOU1
|
hypoxia up-regulated 1
|
2
|
|
971
|
IAPP
|
islet amyloid polypeptide
|
2
|
|
972
|
ICAM1
|
intercellular adhesion molecule 1 (CD54), human rhinovirus receptor
|
1
|
|
973
|
ICAM2
|
intercellular adhesion molecule 2
|
2
|
|
974
|
ICAM3
|
intercellular adhesion molecule 3
|
2
|
|
975
|
ICAM4
|
intercellular adhesion molecule 4 (Landsteiner-Wiener blood group)
|
2
|
|
976
|
ICOS
|
inducible T-cell co-stimulator
|
2
|
|
977
|
ICOSLG
|
inducible T-cell co-stimulator ligand
|
2
|
|
978
|
IDE
|
insulin-degrading enzyme
|
2
|
|
979
|
IDS
|
iduronate 2-sulfatase (Hunter syndrome)
|
2
|
|
980
|
IDUA
|
iduronidase, alpha-L-
|
2
|
|
981
|
IFNA1
|
interferon, alpha 1
|
2
|
|
982
|
IFNAR1
|
interferon (alpha, beta and omega) receptor 1
|
2
|
|
983
|
IFNAR2
|
interferon (alpha, beta and omega) receptor 2
|
2
|
|
984
|
IFNB1
|
interferon, beta 1, fibroblast
|
2
|
|
985
|
IFNG
|
interferon, gamma
|
1
|
|
986
|
IFNGR1
|
interferon gamma receptor 1
|
2
|
|
987
|
IFNGR2
|
interferon gamma receptor 2 (interferon gamma transducer 1)
|
2
|
|
988
|
IFRD1
|
interferon-related developmental regulator 1
|
3
|
|
989
|
IGF1
|
insulin-like growth factor 1 (somatomedin C)
|
1
|
|
990
|
IGF1R
|
insulin-like growth factor 1 receptor
|
1
|
|
991
|
IGF2
|
insulin-like growth factor 2 (somatomedin A)
|
2
|
|
992
|
IGF2AS
|
insulin-like growth factor 2 antisense
|
2
|
|
993
|
IGF2BP1
|
insulin-like growth factor 2 mRNA binding protein 1
|
3
|
|
994
|
IGF2BP2
|
insulin-like growth factor 2 mRNA binding protein 2
|
3
|
|
995
|
IGF2BP3
|
insulin-like growth factor 2 mRNA binding protein 3
|
3
|
|
996
|
IGFBP1
|
insulin-like growth factor binding protein 1
|
3
|
|
997
|
IGFBP3
|
insulin-like growth factor binding protein 3
|
1
|
|
998
|
IKBKAP
|
inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase complex-associated protein
|
3
|
|
999
|
IKBKB
|
inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase beta
|
1
|
|
1000
|
IKBKE
|
inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase epsilon
|
2
|
|
1001
|
IKBKG
|
inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase gamma
|
1
|
|
1002
|
IL10
|
interleukin 10
|
1
|
|
1003
|
IL10RA
|
interleukin 10 receptor, alpha
|
1
|
|
1004
|
IL10RB
|
interleukin 10 receptor, beta
|
1
|
|
1005
|
IL11
|
interleukin 11
|
2
|
|
1006
|
IL12A
|
interleukin 12A (natural killer cell stimulatory factor 1, cytotoxic lymphocyte maturation factor 1, p35)
|
1
|
|
1007
|
IL12B
|
interleukin 12B (natural killer cell stimulatory factor 2, cytotoxic lymphocyte maturation factor 2, p40)
|
1
|
|
1008
|
IL12RB1
|
interleukin 12 receptor, beta 1
|
2
|
|
1009
|
IL12RB2
|
interleukin 12 receptor, beta 2
|
2
|
|
1010
|
IL13
|
interleukin 13
|
2
|
|
1011
|
IL13RA1
|
interleukin 13 receptor, alpha 1
|
2
|
|
1012
|
IL13RA2
|
interleukin 13 receptor, alpha 2
|
2
|
|
1013
|
IL15
|
interleukin 15
|
2
|
|
1014
|
IL16
|
interleukin 16 (lymphocyte chemoattractant factor)
|
2
|
|
1015
|
IL17A
|
interleukin 17A
|
2
|
|
1016
|
IL17B
|
interleukin 17B
|
3
|
|
1017
|
IL17C
|
interleukin 17C
|
3
|
|
1018
|
IL17D
|
interleukin 17D
|
3
|
|
1019
|
IL17F
|
interleukin 17F
|
3
|
|
1020
|
IL17RB
|
interleukin 17 receptor B
|
3
|
|
1021
|
IL18
|
interleukin 18 (interferon-gamma-inducing factor)
|
1
|
|
1022
|
IL18BP
|
interleukin 18 binding protein
|
2
|
|
1023
|
IL18R1
|
interleukin 18 receptor 1
|
2
|
|
1024
|
IL18RAP
|
interleukin 18 receptor accessory protein
|
2
|
|
1025
|
IL1A
|
interleukin 1, alpha
|
1
|
|
1026
|
IL1B
|
interleukin 1, beta
|
1
|
|
1027
|
IL1F10
|
interleukin 1 family, member 10 (theta)
|
2
|
|
1028
|
IL1F5
|
interleukin 1 family, member 5 (delta)
|
2
|
|
1029
|
IL1F6
|
interleukin 1 family, member 6 (epsilon)
|
2
|
|
1030
|
IL1F7
|
interleukin 1 family, member 7 (zeta)
|
2
|
|
1031
|
IL1F9
|
interleukin 1 family, member 9
|
2
|
|
1032
|
IL1R1
|
interleukin 1 receptor, type I
|
1
|
|
1033
|
IL1R2
|
interleukin 1 receptor, type II
|
1
|
|
1034
|
IL1RAP
|
interleukin 1 receptor accessory protein
|
2
|
|
1035
|
IL1RN
|
interleukin 1 receptor antagonist
|
1
|
|
1036
|
IL2
|
interleukin 2
|
1
|
|
1037
|
IL21
|
interleukin 21
|
2
|
|
1038
|
IL23A
|
interleukin 23, alpha subunit p19
|
1
|
|
1039
|
IL23R
|
interleukin 23 receptor
|
2
|
|
1040
|
IL2RA
|
interleukin 2 receptor, alpha
|
2
|
|
1041
|
IL2RB
|
interleukin 2 receptor, beta
|
2
|
|
1042
|
IL2RG
|
interleukin 2 receptor, gamma (severe combined immunodeficiency)
|
1
|
|
1043
|
IL3
|
interleukin 3 (colony-stimulating factor, multiple)
|
2
|
|
1044
|
IL4
|
interleukin 4
|
1
|
|
1045
|
IL4R
|
interleukin 4 receptor
|
2
|
|
1046
|
IL5
|
interleukin 5 (colony-stimulating factor, eosinophil)
|
1
|
|
1047
|
IL5RA
|
interleukin 5 receptor, alpha
|
2
|
|
1048
|
IL6
|
interleukin 6 (interferon, beta 2)
|
1
|
|
1049
|
IL6R
|
interleukin 6 receptor
|
1
|
|
1050
|
IL6ST
|
interleukin 6 signal transducer (gp130, oncostatin M receptor)
|
1
|
|
1051
|
IL7
|
interleukin 7
|
2
|
|
1052
|
IL8
|
interleukin 8
|
1
|
|
1053
|
IL8RA
|
interleukin 8 receptor, alpha
|
2
|
|
1054
|
IL8RB
|
interleukin 8 receptor, beta
|
2
|
|
1055
|
IL9
|
interleukin 9
|
2
|
|
1056
|
INHA
|
inhibin, alpha
|
2
|
|
1057
|
INMT
|
indolethylamine N-methyltransferase
|
2
|
|
1058
|
INPP5D
|
inositol polyphosphate-5-phosphatase, 145kDa
|
2
|
|
1059
|
INS
|
insulin
|
1
|
|
1060
|
INSIG1
|
insulin induced gene 1
|
2
|
|
1061
|
INSIG2
|
insulin induced gene 2
|
1
|
|
1062
|
INSR
|
insulin receptor
|
1
|
|
1063
|
INSRR
|
insulin receptor-related receptor
|
2
|
|
1064
|
IRAK1
|
interleukin-1 receptor-associated kinase 1
|
1
|
|
1065
|
IRAK2
|
interleukin-1 receptor-associated kinase 2
|
2
|
|
1066
|
IRAK3
|
interleukin-1 receptor-associated kinase 3
|
2
|
|
1067
|
IRAK4
|
interleukin-1 receptor-associated kinase 4
|
2
|
|
1068
|
IRF3
|
interferon regulatory factor 3
|
2
|
|
1069
|
IRF5
|
interferon regulatory factor 5
|
1
|
|
1070
|
IRS1
|
insulin receptor substrate 1
|
1
|
|
1071
|
IRS2
|
insulin receptor substrate 2
|
1
|
|
1072
|
IRS4
|
insulin receptor substrate 4
|
1
|
|
1073
|
IRX4
|
iroquois homeobox protein 4
|
2
|
|
1074
|
ISG15
|
ISG15 ubiquitin-like modifier
|
2
|
|
1075
|
ISG20
|
interferon stimulated exonuclease gene 20kDa
|
2
|
|
1076
|
ISL1
|
ISL1 transcription factor, LIM/homeodomain, (islet-1)
|
2
|
|
1077
|
ITGA1
|
integrin, alpha 1
|
3
|
|
1078
|
ITGA2
|
integrin, alpha 2 (CD49B, alpha 2 subunit of VLA-2 receptor)
|
1
|
|
1079
|
ITGA2B
|
integrin, alpha 2b (platelet glycoprotein IIb of IIb/IIIa complex, antigen CD41)
|
2
|
|
1080
|
ITGA4
|
integrin, alpha 4 (antigen CD49D, alpha 4 subunit of VLA-4 receptor)
|
2
|
|
1081
|
ITGA6
|
integrin, alpha 6
|
3
|
|
1082
|
ITGAL
|
integrin, alpha L (antigen CD11A (p180), lymphocyte function-associated antigen 1; alpha polypeptide)
|
2
|
|
1083
|
ITGAM
|
integrin, alpha M (complement component 3 receptor 3 subunit)
|
2
|
|
1084
|
ITGAV
|
integrin, alpha V (vitronectin receptor, alpha polypeptide, antigen CD51)
|
2
|
|
1085
|
ITGB1
|
integrin, beta 1 (fibronectin receptor, beta polypeptide, antigen CD29 includes MDF2, MSK12)
|
2
|
|
1086
|
ITGB2
|
integrin, beta 2 (complement component 3 receptor 3 and 4 subunit)
|
2
|
|
1087
|
ITGB3
|
integrin, beta 3 (platelet glycoprotein IIIa, antigen CD61)
|
1
|
|
1088
|
ITGB4
|
integrin, beta 4
|
2
|
|
1089
|
ITGB5
|
integrin, beta 5
|
2
|
|
1090
|
ITGB6
|
integrin, beta 6
|
2
|
|
1091
|
ITGB7
|
integrin, beta 7
|
2
|
|
1092
|
ITGB8
|
integrin, beta 8
|
3
|
|
1093
|
ITGBL1
|
integrin, beta-like 1 (with EGF-like repeat domains)
|
3
|
|
1094
|
ITIH4
|
inter-alpha (globulin) inhibitor H4 (plasma Kallikrein-sensitive glycoprotein)
|
2
|
|
1095
|
ITK
|
IL2-inducible T-cell kinase
|
3
|
|
1096
|
ITLN1
|
intelectin 1 (galactofuranose binding)
|
2
|
|
1097
|
ITLN2
|
intelectin 2
|
1
|
|
1098
|
ITPKB
|
inositol 1,4,5-trisphosphate 3-kinase B
|
2
|
|
1099
|
ITPR2
|
inositol 1,4,5-triphosphate receptor, type 2
|
2
|
|
1100
|
ITPR3
|
inositol 1,4,5-triphosphate receptor, type 3
|
3
|
|
1101
|
JAG1
|
jagged 1 (Alagille syndrome)
|
2
|
|
1102
|
JAK1
|
Janus kinase 1 (a protein tyrosine kinase)
|
2
|
|
1103
|
JAK2
|
Janus kinase 2 (a protein tyrosine kinase)
|
2
|
|
1104
|
JAK3
|
Janus kinase 3 (a protein tyrosine kinase, leukocyte)
|
2
|
|
1105
|
JUN
|
jun oncogene
|
2
|
|
1106
|
JUP
|
junction plakoglobin
|
2
|
|
1107
|
KALRN
|
kalirin, RhoGEF kinase
|
3
|
|
1108
|
KCNA1
|
potassium voltage-gated channel, shaker-related subfamily, member 1 (episodic ataxia with myokymia)
|
2
|
|
1109
|
KCNA10
|
potassium voltage-gated channel, shaker-related subfamily, member 10
|
2
|
|
1110
|
KCNA5
|
potassium voltage-gated channel, shaker-related subfamily, member 5
|
2
|
|
1111
|
KCNE1
|
potassium voltage-gated channel, Isk-related family, member 1
|
2
|
|
1112
|
KCNE1L
|
KCNE1-like
|
2
|
|
1113
|
KCNE2
|
potassium voltage-gated channel, Isk-related family, member 2
|
1
|
|
1114
|
KCNE3
|
potassium voltage-gated channel, Isk-related family, member 3
|
2
|
|
1115
|
KCNE4
|
potassium voltage-gated channel, Isk-related family, member 4
|
1
|
|
1116
|
KCNH2
|
potassium voltage-gated channel, subfamily H (eag-related), member 2
|
2
|
|
1117
|
KCNH8
|
potassium voltage-gated channel, subfamily H (eag-related), member 8
|
1
|
|
1118
|
KCNJ1
|
potassium inwardly-rectifying channel, subfamily J, member 1
|
2
|
|
1119
|
KCNJ11
|
potassium inwardly-rectifying channel, subfamily J, member 11
|
1
|
|
1120
|
KCNJ2
|
potassium inwardly-rectifying channel, subfamily J, member 2
|
2
|
|
1121
|
KCNJ8
|
potassium inwardly-rectifying channel, subfamily J, member 8
|
2
|
|
1122
|
KCNMB1
|
potassium large conductance calcium-activated channel, subfamily M, beta member 1
|
2
|
|
1123
|
KCNQ1
|
potassium voltage-gated channel, KQT-like subfamily, member 1
|
1
|
|
1124
|
KCNQ4
|
potassium voltage-gated channel, KQT-like subfamily, member 4
|
3
|
|
1125
|
KDR
|
kinase insert domain receptor (a type III receptor tyrosine kinase)
|
2
|
|
1126
|
KIAA0664
|
KIAA0664
|
2
|
|
1127
|
KIF11
|
kinesin family member 11
|
2
|
|
1128
|
KIFC3
|
kinesin family member C3
|
1
|
|
1129
|
KIT
|
v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog
|
3
|
|
1130
|
KITLG
|
KIT ligand
|
2
|
|
1131
|
KL
|
klotho
|
2
|
|
1132
|
KLF1
|
Kruppel-like factor 1 (erythroid)
|
2
|
|
1133
|
KLF2
|
Kruppel-like factor 2 (lung)
|
2
|
|
1134
|
KLK1
|
kallikrein 1
|
2
|
|
1135
|
KLK2
|
kallikrein-related peptidase 2
|
2
|
|
1136
|
KLK3
|
kallikrein-related peptidase 3
|
2
|
|
1137
|
KLKB1
|
kallikrein B, plasma (Fletcher factor) 1
|
2
|
|
1138
|
KNG1
|
kininogen 1
|
1
|
|
1139
|
KRAS
|
v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog
|
3
|
|
1140
|
KRIT1
|
KRIT1, ankyrin repeat containing
|
2
|
|
1141
|
L1CAM
|
L1 cell adhesion molecule
|
2
|
|
1142
|
LAIR1
|
leukocyte-associated immunoglobulin-like receptor 1
|
1
|
|
1143
|
LAMP2
|
lysosomal-associated membrane protein 2
|
2
|
|
1144
|
LAT
|
linker for activation of T cells
|
2
|
|
1145
|
LBP
|
lipopolysaccharide binding protein
|
2
|
|
1146
|
LBR
|
lamin B receptor
|
2
|
|
1147
|
LCAT
|
lecithin-cholesterol acyltransferase
|
1
|
|
1148
|
LCP2
|
lymphocyte cytosolic protein 2 (SH2 domain containing leukocyte protein of 76kDa)
|
3
|
|
1149
|
LCT
|
lactase
|
2
|
|
1150
|
LDHA
|
lactate dehydrogenase A
|
2
|
|
1151
|
LDLR
|
low density lipoprotein receptor (familial hypercholesterolemia)
|
1
|
|
1152
|
LDLRAP1
|
low density lipoprotein receptor adaptor protein 1
|
1
|
|
1153
|
LEFTY1
|
left-right determination factor 1
|
2
|
|
1154
|
LEFTY2
|
left-right determination factor 2
|
2
|
|
1155
|
LEP
|
leptin (obesity homolog, mouse)
|
1
|
|
1156
|
LEPR
|
leptin receptor
|
1
|
|
1157
|
LGALS1
|
lectin, galactoside-binding, soluble, 1 (galectin 1)
|
2
|
|
1158
|
LGALS2
|
lectin, galactoside-binding, soluble, 2
|
2
|
|
1159
|
LGALS3
|
lectin, galactoside-binding, soluble, 3
|
2
|
|
1160
|
LGALS9
|
lectin, galactoside-binding, soluble, 9 (galectin 9)
|
2
|
|
1161
|
LIF
|
leukemia inhibitory factor (cholinergic differentiation factor)
|
2
|
|
1162
|
LILRB1
|
leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 1
|
2
|
|
1163
|
LIMA1
|
LIM domain and actin binding 1
|
3
|
|
1164
|
LIPA
|
lipase A, lysosomal acid, cholesterol esterase (Wolman disease)
|
1
|
|
1165
|
LIPC
|
lipase, hepatic
|
1
|
|
1166
|
LIPE
|
lipase, hormone-sensitive
|
1
|
|
1167
|
LIPF
|
lipase, gastric
|
1
|
|
1168
|
LIPG
|
lipase, endothelial
|
1
|
|
1169
|
LMAN1
|
lectin, mannose-binding, 1
|
2
|
|
1170
|
LMNA
|
lamin A/C
|
1
|
|
1171
|
LMNB1
|
lamin B1
|
2
|
|
1172
|
LMNB2
|
lamin B2
|
2
|
|
1173
|
LMOD1
|
leiomodin 1 (smooth muscle)
|
2
|
|
1174
|
LMOD2
|
leiomodin 2 (cardiac)
|
2
|
|
1175
|
LOC338328
|
high density lipoprotein-binding protein
|
1
|
|
1176
|
LOC387761
|
hypothetical LOC387761
|
2
|
|
1177
|
LPA
|
lipoprotein, Lp(a)
|
1
|
|
1178
|
LPAL2
|
lipoprotein, Lp(a)-like 2
|
2
|
|
1179
|
LPIN1
|
lipin 1
|
1
|
|
1180
|
LPIN3
|
lipin 3
|
3
|
|
1181
|
LPL
|
lipoprotein lipase
|
1
|
|
1182
|
LPXN
|
leupaxin
|
1
|
|
1183
|
LRP1
|
low density lipoprotein-related protein 1 (alpha-2-macroglobulin receptor)
|
1
|
|
1184
|
LRP2
|
low density lipoprotein-related protein 2
|
2
|
|
1185
|
LRP5
|
low density lipoprotein receptor-related protein 5
|
2
|
|
1186
|
LRP6
|
low density lipoprotein receptor-related protein 6
|
2
|
|
1187
|
LRP8
|
low density lipoprotein receptor-related protein 8, apolipoprotein e receptor
|
2
|
|
1188
|
LRPAP1
|
low density lipoprotein receptor-related protein associated protein 1
|
1
|
|
1189
|
LSP1
|
lymphocyte-specific protein 1
|
2
|
|
1190
|
LSS
|
lanosterol synthase (2,3-oxidosqualene-lanosterol cyclase)
|
2
|
|
1191
|
LTA
|
lymphotoxin alpha (TNF superfamily, member 1)
|
1
|
|
1192
|
LTA4H
|
leukotriene A4 hydrolase
|
1
|
|
1193
|
LTB
|
lymphotoxin beta (TNF superfamily, member 3)
|
2
|
|
1194
|
LTB4R
|
leukotriene B4 receptor
|
1
|
|
1195
|
LTB4R2
|
leukotriene B4 receptor 2
|
1
|
|
1196
|
LTBP4
|
latent transforming growth factor beta binding protein 4
|
2
|
|
1197
|
LTC4S
|
leukotriene C4 synthase
|
1
|
|
1198
|
LUM
|
lumican
|
2
|
|
1199
|
LY96
|
lymphocyte antigen 96
|
3
|
|
1200
|